12-31 FALSE 0000835011 2020 Q3 us-gaap:AccountingStandardsUpdate201802Member 0000835011 2020-01-01 2020-09-30 xbrli:shares 0000835011 2020-10-23 iso4217:USD 0000835011 2020-07-01 2020-09-30 0000835011 2019-07-01 2019-09-30 0000835011 2019-01-01 2019-09-30 0000835011 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 iso4217:USD xbrli:shares 0000835011 2020-09-30 0000835011 2019-12-31 xbrli:pure 0000835011 2019-01-01 2019-12-31 0000835011 2018-12-31 0000835011 2019-09-30 0000835011 us-gaap:PreferredStockMember 2019-12-31 0000835011 us-gaap:CommonStockMember 2019-12-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000835011 us-gaap:RetainedEarningsMember 2019-12-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000835011 us-gaap:TreasuryStockMember 2019-12-31 0000835011 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000835011 2020-01-01 2020-03-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000835011 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000835011 us-gaap:PreferredStockMember 2020-03-31 0000835011 us-gaap:CommonStockMember 2020-03-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000835011 us-gaap:RetainedEarningsMember 2020-03-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000835011 us-gaap:TreasuryStockMember 2020-03-31 0000835011 2020-03-31 0000835011 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000835011 2020-04-01 2020-06-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000835011 us-gaap:PreferredStockMember 2020-06-30 0000835011 us-gaap:CommonStockMember 2020-06-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000835011 us-gaap:RetainedEarningsMember 2020-06-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000835011 us-gaap:TreasuryStockMember 2020-06-30 0000835011 2020-06-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000835011 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000835011 us-gaap:PreferredStockMember 2020-09-30 0000835011 us-gaap:CommonStockMember 2020-09-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000835011 us-gaap:RetainedEarningsMember 2020-09-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000835011 us-gaap:TreasuryStockMember 2020-09-30 0000835011 us-gaap:PreferredStockMember 2018-12-31 0000835011 us-gaap:CommonStockMember 2018-12-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000835011 us-gaap:RetainedEarningsMember 2018-12-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000835011 us-gaap:TreasuryStockMember 2018-12-31 0000835011 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000835011 2019-01-01 2019-03-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000835011 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000835011 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2018-12-31 0000835011 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000835011 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000835011 us-gaap:PreferredStockMember 2019-03-31 0000835011 us-gaap:CommonStockMember 2019-03-31 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000835011 us-gaap:RetainedEarningsMember 2019-03-31 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000835011 us-gaap:TreasuryStockMember 2019-03-31 0000835011 2019-03-31 0000835011 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000835011 2019-04-01 2019-06-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000835011 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000835011 us-gaap:PreferredStockMember 2019-06-30 0000835011 us-gaap:CommonStockMember 2019-06-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000835011 us-gaap:RetainedEarningsMember 2019-06-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000835011 us-gaap:TreasuryStockMember 2019-06-30 0000835011 2019-06-30 0000835011 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000835011 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000835011 us-gaap:PreferredStockMember 2019-09-30 0000835011 us-gaap:CommonStockMember 2019-09-30 0000835011 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000835011 us-gaap:RetainedEarningsMember 2019-09-30 0000835011 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000835011 us-gaap:TreasuryStockMember 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:BrownGoodsMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:BrownGoodsMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:BrownGoodsMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:BrownGoodsMember 2019-01-01 2019-09-30 0000835011 mgpi:WhiteGoodsMember mgpi:DistilleryProductsMember 2020-07-01 2020-09-30 0000835011 mgpi:WhiteGoodsMember mgpi:DistilleryProductsMember 2019-07-01 2019-09-30 0000835011 mgpi:WhiteGoodsMember mgpi:DistilleryProductsMember 2020-01-01 2020-09-30 0000835011 mgpi:WhiteGoodsMember mgpi:DistilleryProductsMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:PremiumBeverageAlcoholMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:PremiumBeverageAlcoholMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:PremiumBeverageAlcoholMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:PremiumBeverageAlcoholMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:IndustrialAlcoholMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:IndustrialAlcoholMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:IndustrialAlcoholMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:IndustrialAlcoholMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:FoodGradeAlcoholMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:FoodGradeAlcoholMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:FoodGradeAlcoholMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:FoodGradeAlcoholMember 2019-01-01 2019-09-30 0000835011 mgpi:FuelGradeAlcoholMember mgpi:DistilleryProductsMember 2020-07-01 2020-09-30 0000835011 mgpi:FuelGradeAlcoholMember mgpi:DistilleryProductsMember 2019-07-01 2019-09-30 0000835011 mgpi:FuelGradeAlcoholMember mgpi:DistilleryProductsMember 2020-01-01 2020-09-30 0000835011 mgpi:FuelGradeAlcoholMember mgpi:DistilleryProductsMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:DistillersFeedAndRelatedCoProductsMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:DistillersFeedAndRelatedCoProductsMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:DistillersFeedAndRelatedCoProductsMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:DistillersFeedAndRelatedCoProductsMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:WarehouseServicesMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:WarehouseServicesMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:WarehouseServicesMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember mgpi:WarehouseServicesMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember 2020-07-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember 2019-07-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember 2020-01-01 2020-09-30 0000835011 mgpi:DistilleryProductsMember 2019-01-01 2019-09-30 0000835011 mgpi:SpecialtyWheatStarchesMember mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 mgpi:SpecialtyWheatStarchesMember mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 mgpi:SpecialtyWheatStarchesMember mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 mgpi:SpecialtyWheatStarchesMember mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 mgpi:SpecialtyWheatProteinsMember mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 mgpi:SpecialtyWheatProteinsMember mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 mgpi:SpecialtyWheatProteinsMember mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 mgpi:SpecialtyWheatProteinsMember mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 mgpi:CommodityWheatStarchMember mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 mgpi:CommodityWheatStarchMember mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 mgpi:CommodityWheatStarchMember mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 mgpi:CommodityWheatStarchMember mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 mgpi:CommodityWheatProteinMember mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 mgpi:CommodityWheatProteinMember mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 mgpi:CommodityWheatProteinMember mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 mgpi:CommodityWheatProteinMember mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 mgpi:DistilleryProductsMember 2019-12-31 0000835011 mgpi:IngredientSolutionsMember 2019-12-31 0000835011 mgpi:DistilleryProductsMember 2020-09-30 0000835011 mgpi:IngredientSolutionsMember 2020-09-30 0000835011 us-gaap:TradeNamesMember 2020-09-30 0000835011 us-gaap:TradeNamesMember 2019-12-31 0000835011 mgpi:CreditAgreementDue2025Member 2020-09-30 0000835011 mgpi:CreditAgreementDue2025Member 2019-12-31 0000835011 mgpi:CreditAgreementDue2022Member 2019-12-31 0000835011 mgpi:CreditAgreementDue2022Member 2020-09-30 0000835011 mgpi:SecuredPromissoryNoteDue2022Member us-gaap:SecuredDebtMember 2020-09-30 0000835011 mgpi:SecuredPromissoryNoteDue2022Member us-gaap:SecuredDebtMember 2019-12-31 0000835011 us-gaap:SecuredDebtMember mgpi:PrudentialNotePurchaseAgreement3.53Member 2020-09-30 0000835011 us-gaap:SecuredDebtMember mgpi:PrudentialNotePurchaseAgreement3.53Member 2019-12-31 0000835011 mgpi:PrudentialNotePurchaseAgreement3.80Member us-gaap:SecuredDebtMember 2020-09-30 0000835011 mgpi:PrudentialNotePurchaseAgreement3.80Member us-gaap:SecuredDebtMember 2019-12-31 0000835011 mgpi:CreditAgreementDue2025Member 2020-02-14 0000835011 mgpi:CreditAgreementDue2025Member 2020-01-01 2020-09-30 0000835011 us-gaap:SeniorNotesMember mgpi:PrudentialNotePurchaseAgreement3.53Member 2020-09-30 0000835011 us-gaap:SeniorNotesMember mgpi:PrudentialNotePurchaseAgreement3.53Member 2020-01-01 2020-09-30 0000835011 us-gaap:SeniorNotesMember mgpi:PrudentialNotePurchaseAgreement3.53Member 2017-01-01 2017-12-31 0000835011 mgpi:PrudentialNotePurchaseAgreement3.80Member us-gaap:SeniorNotesMember 2019-01-01 2019-12-31 0000835011 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0000835011 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000835011 2019-02-25 0000835011 mgpi:RansomwareCyberAttackMember 2020-05-01 2020-05-31 mgpi:numberOfLawsuits 0000835011 mgpi:CleanAirActViolationMember 2020-09-30 0000835011 mgpi:EPAAdministrativeCivilPenaltyMember 2020-09-30 mgpi:plan 0000835011 us-gaap:RestrictedStockUnitsRSUMember mgpi:EmployeeEquityIncentivePlanMember 2020-01-01 2020-09-30 0000835011 mgpi:EmployeeEquityIncentivePlanMember 2020-09-30 0000835011 us-gaap:RestrictedStockUnitsRSUMember mgpi:NonEmployeeDirectorEquityIncentivePlanMember 2020-01-01 2020-09-30 0000835011 mgpi:NonEmployeeDirectorEquityIncentivePlanMember 2020-09-30 0000835011 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0000835011 mgpi:ShorttermIncentivePlanMember 2020-09-30 0000835011 mgpi:ShorttermIncentivePlanMember 2019-12-31 mgpi:segment 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2020-07-01 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2019-07-01 2019-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2020-01-01 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2019-01-01 2019-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2020-07-01 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2019-07-01 2019-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2020-01-01 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2019-01-01 2019-09-30 0000835011 us-gaap:CorporateNonSegmentMember 2020-07-01 2020-09-30 0000835011 us-gaap:CorporateNonSegmentMember 2019-07-01 2019-09-30 0000835011 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-09-30 0000835011 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:DistilleryProductsMember 2019-12-31 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2020-09-30 0000835011 us-gaap:OperatingSegmentsMember mgpi:IngredientSolutionsMember 2019-12-31 0000835011 us-gaap:CorporateNonSegmentMember 2020-09-30 0000835011 us-gaap:CorporateNonSegmentMember 2019-12-31 0000835011 us-gaap:SubsequentEventMember 2020-10-27 2020-10-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________________ to _________________________________
Commission File Number: 0-17196
MGP INGREDIENTS, INC.
(Exact name of registrant as specified in its charter)

Kansas | 45-4082531
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)

100 Commercial Street |
Atchison | Kansas | 66002
(Address of principal executive offices) | (Zip Code)

(913) 367-1480
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, no par value | MGPI | NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an “emerging growth company.” See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
x Large accelerated filer ☐ Accelerated filer
☐ Non-accelerated filer (Do not check if smaller reporting company) ☐ Smaller Reporting Company
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐Yes x No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
16,915,845 shares of Common Stock, no par value as of October 23, 2020

INDEX

PART I. FINANCIAL INFORMATION | Page
| Item 1. | Condensed Consolidated Financial Statements (Unaudited) |
| Condensed Consolidated Statements of Income (Unaudited) | 3
| Condensed Consolidated Statements of Comprehensive Income (Unaudited) | 4
| Condensed Consolidated Balance Sheets (Unaudited) | 5
| Condensed Consolidated Statements of Cash Flows (Unaudited) | 6
| Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) | 7
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 28
| Item 4. | Controls and Procedures | 29
PART II. OTHER INFORMATION |
| Item 1. | Legal Proceedings | 29
| Item 1A. | Risk Factors | 29
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 31
| Item 3. | Defaults Upon Senior Securities | 31
| Item 4. | Mine Safety Disclosures | 31
| Item 5. | Other Information | 31
| Item 6. | Exhibits | 32

METHOD OF PRESENTATION
Throughout this Report, when we refer to “the Company,” “MGP,” “we,” “us,” “our,” and words of similar import, we are referring to the combined business of MGP Ingredients, Inc. and its consolidated subsidiaries, except to the extent that the context otherwise indicates. In this document, for any references to Note 1 through Note 10, refer to the Notes to Unaudited Condensed Consolidated Financial Statements in Item 1.
All amounts in this report, except for share, par values, bushels, gallons, pounds, mmbtu, proof gallons, per share, per bushel, per gallon, per proof gallon and percentage amounts, are shown in thousands unless otherwise noted.
2

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(Dollars in thousands, except share and per share amounts)

| Quarter Ended September 30, |  | Year to Date Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Sales | $ | 102,964 |  |  | $ | 90,685 |  |  | $ | 294,606 |  |  | $ | 270,282 |
Cost of sales | 79,802 |  |  | 71,895 |  |  | 227,531 |  |  | 215,310 |
Gross profit | 23,162 |  |  | 18,790 |  |  | 67,075 |  |  | 54,972 |
Selling, general and administrative expenses | 9,510 |  |  | 7,186 |  |  | 28,377 |  |  | 23,981 |
Operating income | 13,652 |  |  | 11,604 |  |  | 38,698 |  |  | 30,991 |
Interest expense, net and other | (409) |  |  | (364) |  |  | (1,349) |  |  | (937) |
Income before income taxes | 13,243 |  |  | 11,240 |  |  | 37,349 |  |  | 30,054 |
Income tax expense | 2,862 |  |  | 3,025 |  |  | 8,636 |  |  | 4,208 |
Net income | 10,381 |  |  | 8,215 |  |  | 28,713 |  |  | 25,846 |
Income attributable to participating securities | 69 |  |  | 54 |  |  | 192 |  |  | 171 |
Net income attributable to common shareholders and used in earnings per share calculation | $ | 10,312 |  |  | $ | 8,161 |  |  | $ | 28,521 |  |  | $ | 25,675 |
Basic and diluted weighted average common shares | 16,916,675 |  |  | 17,027,068 |  |  | 16,943,130 |  |  | 17,006,226 |
Basic and diluted earnings per common share | $ | 0.61 |  |  | $ | 0.48 |  |  | $ | 1.68 |  |  | $ | 1.51 |

See accompanying notes to unaudited condensed consolidated financial statements
3

MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
(Dollars in thousands)

| Quarter Ended September 30, |  | Year to Date Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Net income | $ | 10,381 |  |  | $ | 8,215 |  |  | $ | 28,713 |  |  | $ | 25,846 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Change in Company-sponsored post-employment benefit plan | 74 |  |  | (7) |  |  | 89 |  |  | (9) |
Comprehensive income | $ | 10,455 |  |  | $ | 8,208 |  |  | $ | 28,802 |  |  | $ | 25,837 |

See accompanying notes to unaudited condensed consolidated financial statements
4

MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands)

|  | September 30, 2020 |  | December 31, 2019
Current Assets |  |  |  |
Cash and cash equivalents |  | $ | 19,966 |  |  | $ | 3,309 |
Receivables (less allowance for doubtful accounts at September 30, 2020, and December 31, 2019 - $24) |  | 52,673 |  |  | 40,931 |
Inventory |  | 142,798 |  |  | 136,931 |
Prepaid expenses |  | 3,928 |  |  | 2,048 |
Refundable income taxes |  | 1,719 |  |  | 987 |
Total current assets |  | 221,084 |  |  | 184,206 |
Property, plant, and equipment |  | 323,755 |  |  | 313,958 |
Less accumulated depreciation and amortization |  | (194,112) |  |  | (185,539) |
Property, plant, and equipment, net |  | 129,643 |  |  | 128,419 |
Operating lease right-of-use assets, net |  | 5,362 |  |  | 6,490 |
Other assets |  | 5,657 |  |  | 3,482 |
Total assets |  | $ | 361,746 |  |  | $ | 322,597 |
Current Liabilities |  |  |  |
Current maturities of long-term debt |  | $ | 412 |  |  | $ | 401 |
Accounts payable |  | 29,055 |  |  | 29,511 |
Accrued expenses |  | 14,938 |  |  | 9,383 |
Total current liabilities |  | 44,405 |  |  | 39,295 |
Long-term debt, less current maturities |  | 40,363 |  |  | 40,658 |
Credit agreement - revolver |  | 13,733 |  |  | 1 |
Long-term operating lease liabilities |  | 3,226 |  |  | 4,267 |
Deferred credits |  | 1,035 |  |  | 1,233 |
Other noncurrent liabilities |  | 4,818 |  |  | 4,170 |
Deferred income taxes |  | 2,165 |  |  | 1,929 |
Total liabilities |  | 109,745 |  |  | 91,553 |
Commitments and Contingencies (Note 7) |  |  |  |
Stockholders’ Equity |  |  |  |
Capital stock |  |  |  |
Preferred, 5% non-cumulative; $10 par value; authorized 1,000 shares; issued and outstanding 437 shares |  | 4 |  |  | 4 |
Common stock |  |  |  |
No par value; authorized 40,000,000 shares; issued 18,115,965 shares at September 30, 2020 and December 31, 2019; and 16,913,313 and 17,028,125 shares outstanding at September 30, 2020 and December 31, 2019, respectively |  | 6,715 |  |  | 6,715 |
Additional paid-in capital |  | 15,284 |  |  | 14,029 |
Retained earnings |  | 253,354 |  |  | 230,784 |
Accumulated other comprehensive loss |  | (157) |  |  | (246) |
Treasury stock, at cost, 1,202,652 and 1,087,840 at September 30, 2020 and December 31, 2019, respectively |  | (23,199) |  |  | (20,242) |
Total stockholders’ equity |  | 252,001 |  |  | 231,044 |
Total liabilities and stockholders’ equity |  | $ | 361,746 |  |  | $ | 322,597 |

See accompanying notes to unaudited condensed consolidated financial statements
5

MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)

| Year to Date Ended September 30,
| 2020 |  | 2019
Cash Flows from Operating Activities |  |  |
Net income | $ | 28,713 |  |  | $ | 25,846 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 9,618 |  |  | 8,537 |
Loss (gain) on sale of assets | 337 |  |  | (138) |
Share-based compensation | 2,693 |  |  | 2,752 |
Deferred income taxes, including change in valuation allowance | 460 |  |  | 952 |
Changes in operating assets and liabilities: |  |  |
Receivables, net | (11,683) |  |  | (1,757) |
Inventory | (5,673) |  |  | (17,424) |
Prepaid expenses | (2,032) |  |  | (326) |
Refundable income taxes | (673) |  |  | (2,138) |
Accounts payable | 2,196 |  |  | (331) |
Accrued expenses | 5,647 |  |  | (3,236) |
Deferred credits | (198) |  |  | (249) |
Other, net | 52 |  |  | (75) |
Net cash provided by operating activities | 29,457 |  |  | 12,413 |
Cash Flows from Investing Activities |  |  |
Additions to property, plant, and equipment | (13,507) |  |  | (10,375) |
Deferred compensation plan investments | — |  |  | (1,189) |
Acquisition of business | (2,750) |  |  | — |
Proceeds from sale of property | 688 |  |  | — |
Other, net | 56 |  |  | — |
Net cash used in investing activities | (15,513) |  |  | (11,564) |
Cash Flows from Financing Activities |  |  |
Payment of dividends and dividend equivalents | (6,144) |  |  | (5,141) |
Purchase of treasury stock | (4,395) |  |  | (5,470) |
Loan fees paid related to borrowings | (1,148) |  |  | — |
Proceeds from long-term debt | — |  |  | 20,000 |
Principal payments on long-term debt | (300) |  |  | (288) |
Proceeds from credit agreement - revolver | 54,700 |  |  | 14,140 |
Payments on credit agreement - revolver | (40,000) |  |  | (24,640) |
Other, net | — |  |  | (78) |
Net cash provided by (used in) financing activities | 2,713 |  |  | (1,477) |
Increase (decrease) in cash and cash equivalents | 16,657 |  |  | (628) |
Cash and cash equivalents, beginning of period | 3,309 |  |  | 5,025 |
Cash and cash equivalents, end of period | $ | 19,966 |  |  | $ | 4,397 |

See accompanying notes to unaudited condensed consolidated financial statements
6

MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
For Year to Date Ended September 30, 2020
(Unaudited) (Dollars in thousands)

|  | Capital Stock Preferred |  | Issued Common |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Treasury Stock |  | Total
Balance, December 31, 2019 |  | $ | 4 |  |  | $ | 6,715 |  |  | $ | 14,029 |  |  | $ | 230,784 |  |  | $ | (246) |  |  | $ | (20,242) |  |  | $ | 231,044 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 9,842 |  |  | — |  |  | — |  |  | 9,842 |
Other comprehensive loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (6) |  |  | — |  |  | (6) |
Dividends and dividend equivalents of $0.12 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (2,059) |  |  | — |  |  | — |  |  | (2,059) |
Share-based compensation |  | — |  |  | — |  |  | 902 |  |  | — |  |  | — |  |  | — |  |  | 902 |
Stock shares awarded, forfeited or vested |  | — |  |  | — |  |  | (567) |  |  | — |  |  | — |  |  | 804 |  |  | 237 |
Stock shares repurchased |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,395) |  |  | (4,395) |
Balance, March 31, 2020 |  | 4 |  |  | 6,715 |  |  | 14,364 |  |  | 238,567 |  |  | (252) |  |  | (23,833) |  |  | 235,565 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 8,490 |  |  | — |  |  | — |  |  | 8,490 |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | 21 |  |  | — |  |  | 21 |
Dividends and dividend equivalents of $0.12 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (2,041) |  |  | — |  |  | — |  |  | (2,041) |
Share-based compensation |  | — |  |  | — |  |  | 662 |  |  | — |  |  | — |  |  | — |  |  | 662 |
Balance, June 30, 2020 |  | 4 |  |  | 6,715 |  |  | 15,026 |  |  | 245,016 |  |  | (231) |  |  | (23,833) |  |  | 242,697 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 10,381 |  |  | — |  |  | — |  |  | 10,381 |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | 74 |  |  | — |  |  | 74 |
Dividends and dividend equivalents of $0.12 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (2,043) |  |  | — |  |  | — |  |  | (2,043) |
Share-based compensation |  | — |  |  | — |  |  | 258 |  |  | — |  |  | — |  |  | — |  |  | 258 |
Stock shares awarded, forfeited, or vested |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 634 |  |  | 634 |
Balance, September 30, 2020 |  | $ | 4 |  |  | $ | 6,715 |  |  | $ | 15,284 |  |  | $ | 253,354 |  |  | $ | (157) |  |  | $ | (23,199) |  |  | $ | 252,001 |

See accompanying notes to unaudited condensed consolidated financial statements
7

MGP INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
For Year to Date Ended September 30, 2019
(Unaudited) (Dollars in thousands)

|  | Capital Stock Preferred |  | Issued Common |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Treasury Stock |  | Total
Balance, December 31, 2018 |  | $ | 4 |  |  | $ | 6,715 |  |  | $ | 15,375 |  |  | $ | 198,914 |  |  | $ | (164) |  |  | $ | (19,403) |  |  | $ | 201,441 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 9,720 |  |  | — |  |  | — |  |  | 9,720 |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | 14 |  |  | — |  |  | 14 |
Dividends and dividend equivalents of $0.10 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (1,714) |  |  | — |  |  | — |  |  | (1,714) |
Share-based compensation |  | — |  |  | — |  |  | 1,031 |  |  | — |  |  | — |  |  | — |  |  | 1,031 |
Stock shares awarded, forfeited or vested |  | — |  |  | — |  |  | (3,770) |  |  | — |  |  | — |  |  | 3,864 |  |  | 94 |
Stock shares repurchased |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5,467) |  |  | (5,467) |
Adjustment related to Accounting Standards Update 2018-02 adoption |  | — |  |  | — |  |  | — |  |  | (69) |  |  | 69 |  |  | — |  |  | — |
Balance, March 31, 2019 |  | 4 |  |  | 6,715 |  |  | 12,636 |  |  | 206,851 |  |  | (81) |  |  | (21,006) |  |  | 205,119 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 7,911 |  |  | — |  |  | — |  |  | 7,911 |
Other comprehensive loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (16) |  |  | — |  |  | (16) |
Dividends and dividend equivalents of $0.10 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (1,713) |  |  | — |  |  | — |  |  | (1,713) |
Share-based compensation |  | — |  |  | — |  |  | 481 |  |  | — |  |  | — |  |  | — |  |  | 481 |
Stock shares awarded, forfeited, or vested |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 660 |  |  | 660 |
Balance, June 30, 2019 |  | 4 |  |  | 6,715 |  |  | 13,117 |  |  | 213,049 |  |  | (97) |  |  | (20,346) |  |  | 212,442 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | 8,215 |  |  | — |  |  | — |  |  | 8,215 |
Other comprehensive loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (7) |  |  | — |  |  | (7) |
Dividends and dividend equivalents of $0.10 per common share and per restricted stock unit, net of estimated forfeitures |  | — |  |  | — |  |  | — |  |  | (1,713) |  |  | — |  |  | — |  |  | (1,713) |
Share-based compensation |  | — |  |  | — |  |  | 484 |  |  | — |  |  | — |  |  | — |  |  | 484 |
Stock shares repurchased |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (1) |
Balance, September 30, 2019 |  | $ | 4 |  |  | $ | 6,715 |  |  | $ | 13,601 |  |  | $ | 219,551 |  |  | $ | (104) |  |  | $ | (20,347) |  |  | $ | 219,420 |

See accompanying notes to unaudited condensed consolidated financial statements
8

MGP INGREDIENTS, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, unless otherwise noted)
Note 1. Accounting Policies and Basis of Presentation
The Company. MGP Ingredients, Inc. (“the Company,” and “MGP”) is a Kansas corporation headquartered in Atchison, Kansas and is a leading producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. Distilled spirits include premium bourbon and rye whiskeys and grain neutral spirits, including vodka and gin. MGP is also a top producer of high quality industrial alcohol for use in both food and non-food applications. The Company’s protein and starch food ingredients provide a host of functional, nutritional, and sensory benefits for a wide range of food products to serve the packaged goods industry. The Company’s distillery products are derived from corn and other grains (including rye, barley, wheat, barley malt, and milo), and its ingredient products are derived from wheat flour. The majority of the Company’s sales are made directly, or through distributors, to manufacturers and processors of finished packaged goods or to bakeries.
Basis of Presentation and Principles of Consolidation. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. These unaudited condensed consolidated financial statements as of and for the quarter ended September 30, 2020, should be read in conjunction with the consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (“SEC”). The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Certain amounts in 2019 consolidated financial statements have been reclassified to conform to the 2020 presentation.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal and recurring adjustments) necessary to fairly present the results for interim periods in accordance with U.S. generally accepted accounting principles (“GAAP”). Pursuant to the rules and regulations of the SEC, certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted.
Use of Estimates. The financial reporting policies of the Company conform to GAAP. The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The application of certain of these policies places demands on management’s judgment, with financial reporting results relying on estimation about the effects of matters that are inherently uncertain, inclusive of the effects related to COVID-19. For all of these policies, management cautions that future events rarely develop as forecast, and estimates routinely require adjustment and may require material adjustment.
Inventory. Inventory includes finished goods, raw materials in the form of agricultural commodities used in the production process and certain maintenance and repair items. Bourbon and whiskeys are normally aged in barrels for several years, following industry practice; all barreled bourbon and whiskey is classified as a current asset. The Company includes warehousing, insurance, and other carrying charges applicable to barreled whiskey in inventory costs.
9

Inventories are stated at lower of cost or net realizable value on the first-in, first-out, or FIFO, method. Inventory valuations are impacted by constantly changing prices paid for key materials, primarily corn. Inventory consists of the following:

|  | September 30, 2020 |  | December 31, 2019
Finished goods |  | $ | 17,205 |  |  | $ | 16,654 |
Barreled distillate (bourbons and whiskeys) |  | 108,406 |  |  | 104,249 |
Raw materials |  | 5,234 |  |  | 4,920 |
Work in process |  | 2,439 |  |  | 1,766 |
Maintenance materials |  | 8,054 |  |  | 8,200 |
Other |  | 1,460 |  |  | 1,142 |
Total |  | $ | 142,798 |  |  | $ | 136,931 |

Revenue Recognition. Revenue is recognized when control of the promised goods or services, through performance obligations by the Company, is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for the performance obligations. The term between invoicing and when payment is due is not significant and the period between when the entity transfers the promised good or service to the customer and when the customer pays for that good or service is one year or less.
Excise taxes that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer are excluded from revenue. Revenue is recognized for the sale of products at the point in time finished products are delivered to the customer in accordance with shipping terms. This is a faithful depiction of the satisfaction of the performance obligation because, at the point control passes to the customer, the customer has legal title and the risk and rewards of ownership have transferred, and the customer has present obligation to pay.
The Company’s Distillery Products segment routinely enters into bill and hold arrangements, whereby the Company produces and sells aged and unaged distillate to customers, and the product is barreled at the customer’s request and warehoused at a Company location for an extended period of time in accordance with directions received from the Company’s customers. Even though the aged and unaged distillate remains in the Company’s possession, a sale is recognized at the point in time when the customer obtains control of the product. Control is transferred to the customer in bill and hold transactions when: customer acceptance specifications have been met, legal title has transferred, the customer has a present obligation to pay for the product, and the risk and rewards of ownership have transferred to the customer. Additionally, all the following bill and hold criteria have to be met in order for control to be transferred to the customer: the customer has requested the product be warehoused, the product has been identified as separately belonging to the customer, the product is currently ready for physical transfer to the customer, and the Company does not have the ability to use the product or direct it to another customer.
Warehouse services revenue is recognized over the time that warehouse services are rendered and as they are rendered. This is a faithful depiction of the satisfaction of the performance obligation because control of the aging products has already passed to the customer and there are no additional performance activities required by the Company, except as requested by the customer. The performance of the service activities, as requested, is invoiced as satisfied and revenue is concurrently recognized.
Income Taxes. The Company accounts for income taxes using an asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is recognized if it is “more likely than not” that at least some portion of the deferred tax asset will not be realized.
Earnings Per Share (“EPS”). Basic and diluted EPS are computed using the two-class method, which is an earnings allocation formula that determines net income per share for each class of Common Stock and participating security according to dividends declared and participation rights in undistributed earnings. Per share amounts are computed by dividing net income attributable to common shareholders by the weighted average shares outstanding during each year during the period.
10

Goodwill and Other Intangible Assets. The Company records goodwill and other indefinite-lived intangible assets in connection with various acquisitions of businesses and allocates the goodwill and other indefinite-lived intangible assets to its respective reporting units. The Company tests goodwill for impairment at least annually, in the fourth quarter, or on an interim basis if events and circumstances occur that would indicate it is more likely than not that the fair value of a reporting unit is less than the carrying value. To the extent that the carrying amount exceeds fair value, an impairment of goodwill is recognized and allocated to the reporting units. Judgment is required in the determination of reporting units, the assignment of assets and liabilities to reporting units, including goodwill, and the determination of fair value of the reporting units. The fair value of the reporting units was estimated using third party independent appraisals. The Company separately evaluates indefinite-lived intangible assets for impairment. As of September 30, 2020, the Company determined that goodwill was not impaired.
Fair Value of Financial Instruments. The Company determines the fair values of its financial instruments based on a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The hierarchy is broken down into three levels based upon the observability of inputs. Fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs include quoted prices for similar assets and liabilities in active markets and inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs are unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value in its entirety requires judgment and considers factors specific to the asset or liability.
The Company’s short term financial instruments include cash and cash equivalents, accounts receivables and accounts payable. The carrying value of the short term financial instruments approximates the fair value due to their short term nature. These financial instruments have no stated maturities or the financial instruments have short term maturities that approximate market.
The fair value of the Company’s debt is estimated based on current market interest rates for debt with similar maturities and credit quality. The fair value of the Company’s debt was $61,698 and $42,534 at September 30, 2020 and December 31, 2019, respectively. The financial statement carrying value of total debt was $54,508 (including unamortized loan fees) and $41,060 (including unamortized loan fees) at September 30, 2020 and December 31, 2019, respectively. These fair values are considered Level 2 under the fair value hierarchy. Fair value disclosure for deferred compensation plan investments is included in Note 8.
Recently Adopted Accounting Standard Updates. The Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326) and subsequent updates. The accounting standard changes the methodology for measuring credit losses on financial instruments and the timing when such losses are recorded. The Company adopted this standard on January 1, 2020 using the modified retrospective approach, and it had no impact on its consolidated financial statements and disclosures.
ASU 2017-04, Simplifying the Test for Goodwill Impairment, which simplifies the accounting for goodwill by eliminating the step 2 from the goodwill impairment test. An impairment in goodwill is recognized if the carrying amount of the reporting unit exceeds its fair value. The Company adopted this standard on January 1, 2020 on a prospective basis. The adoption of this standard had no impact on the Company's consolidated financial statements and disclosures.
ASU 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosure requirements on fair value measurements. The Company adopted this guidance on January 1, 2020 and it had no impact on its consolidated financial statements and disclosures.
ASU 2019-12, Simplifying the Accounting for Income Taxes, which clarifies and simplifies certain aspects of accounting for income taxes. This standard requires certain aspects to be adopted on either a retrospective or modified retrospective basis, while others apply prospectively. This guidance is effective for fiscal years beginning after December 15, 2020 and early adoption is permitted. The Company elected to early adopt this standard on January 1, 2020 and it had no impact on its consolidated financial statements and disclosures.
11

Note 2. Revenue
The following table presents the Company’s sales by segment and major products and services:

| Quarter Ended September 30, |  | Year to Date Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Distillery Products |  |  |  |  |  |  |
Brown goods | $ | 34,365 |  |  | $ | 26,606 |  |  | $ | 88,975 |  |  | $ | 79,054 |
White goods | 16,362 |  |  | 15,359 |  |  | 48,306 |  |  | 47,232 |
Premium beverage alcohol | 50,727 |  |  | 41,965 |  |  | 137,281 |  |  | 126,286 |
Industrial alcohol | 19,461 |  |  | 19,525 |  |  | 64,032 |  |  | 60,604 |
Food grade alcohol | 70,188 |  |  | 61,490 |  |  | 201,313 |  |  | 186,890 |
Fuel grade alcohol | 1,274 |  |  | 1,438 |  |  | 3,970 |  |  | 4,337 |
Distillers feed and related co-products | 6,119 |  |  | 6,630 |  |  | 19,889 |  |  | 19,906 |
Warehouse services | 4,041 |  |  | 3,737 |  |  | 11,641 |  |  | 10,762 |
Total Distillery Products | 81,622 |  |  | 73,295 |  |  | 236,813 |  |  | 221,895 |
Ingredient Solutions |  |  |  |  |  |  |
Specialty wheat starches | 11,604 |  |  | 8,432 |  |  | 30,938 |  |  | 22,523 |
Specialty wheat proteins | 7,994 |  |  | 6,166 |  |  | 20,372 |  |  | 15,884 |
Commodity wheat starches | 1,596 |  |  | 2,300 |  |  | 5,247 |  |  | 7,575 |
Commodity wheat proteins | 148 |  |  | 492 |  |  | 1,236 |  |  | 2,405 |
Total Ingredient Solutions | 21,342 |  |  | 17,390 |  |  | 57,793 |  |  | 48,387 |
Total sales | $ | 102,964 |  |  | $ | 90,685 |  |  | $ | 294,606 |  |  | $ | 270,282 |

The Company generates revenues from the Distillery Products segment by the sale of products and by providing warehouse services related to the storage and aging of customer products. The Company generates revenues from the Ingredient Solutions segment by the sale of products. Revenue related to sales of products is recognized at a point in time whereas revenue generated from warehouse services is recognized over time. Contracts with customers in both segments include a single performance obligation (either the sale of products or the provision of warehouse services).
Note 3. Goodwill and Other Intangible Assets
The Company records goodwill and indefinite-lived intangible assets in connection with various acquisitions of businesses and allocates the goodwill and indefinite-lived intangible assets to its respective reporting units. Goodwill and indefinite-lived intangible assets are included in Other assets on the Condensed Consolidated Balance Sheets. Changes in carrying amount of goodwill and indefinite-lived intangible assets by business segment were as follows:

| Distillery Products (a) |  | Ingredient Solutions |  | Total (a)
Balance, December 31, 2019 | $ | 1,850 |  |  | $ | — |  |  | $ | 1,850 |
Acquisitions | 1,739 |  |  | — |  |  | 1,739 |
Balance, September 30, 2020 | $ | 3,589 |  |  | $ | — |  |  | $ | 3,589 |

(a) Includes $890 and $350 of trade names at September 30, 2020 and December 31, 2019, respectively. Trade names are considered indefinite-lived intangible assets.
12

Note 4. Corporate Borrowings
The following table presents the Company’s outstanding indebtedness:

Description(a) |  | September 30, 2020 |  | December 31, 2019
Credit Agreement - Revolver, 1.16% (variable rate) due 2025 |  | $ | 15,000 |  |  | $ | — |
Previous Credit Agreement - Revolver, 3.19% (variable rate) due 2022 |  | — |  |  | 300 |
Secured Promissory Note, 3.71% (fixed rate) due 2022 |  | 909 |  |  | 1,208 |
Prudential Note Purchase Agreement, 3.53% (fixed rate) due 2027 |  | 20,000 |  |  | 20,000 |
Prudential Note Purchase Agreement, 3.80% (fixed rate) due 2029 |  | 20,000 |  |  | 20,000 |
Total indebtedness outstanding |  | 55,909 |  |  | 41,508 |
Less unamortized loan fees(b) |  | (1,401) |  |  | (448) |
Total indebtedness outstanding, net |  | 54,508 |  |  | 41,060 |
Less current maturities of long-term debt |  | (412) |  |  | (401) |
Long-term debt and Credit Agreement - Revolver |  | $ | 54,096 |  |  | $ | 40,659 |

(a) Interest rates are as of September 30, 2020, except for the Previous Credit Agreement which is as of December 31, 2019.
(b) Loan fees are being amortized over the life of the Credit Agreement and Note Purchase Agreement.
Credit Agreements. On February 14, 2020, the Company entered into a new credit agreement (the "Credit Agreement") with multiple participants lead by Wells Fargo Bank, National Association ("Wells Fargo Bank") that matures on February 14, 2025. The Credit Agreement replaced the Company's $150,000 Credit Agreement ("Previous Credit Agreement) with Wells Fargo Bank. The Credit Agreement provides for a $300,000 revolving credit facility. The Company may increase the facility from time to time by an aggregate principal amount of up to $100,000 provided certain conditions are satisfied and at the discretion of the lenders. The Company incurred $1,148 of new loan fees related to the Credit Agreement. The Credit Agreement includes certain requirements and covenants, which the Company was in compliance with at September 30, 2020. As of September 30, 2020, the Company’s total outstanding borrowings under the Credit Agreement were $15,000 leaving $285,000 available.
Note Purchase Agreements. The Company’s Note Purchase and Private Shelf Agreement (the “Note Purchase Agreement”), as amended by the First Amendment to Private Shelf Agreement as of February 14, 2020 and the Second Amendment to Private Shelf Agreement as of September 30, 2020 with PGIM, Inc., an affiliate of Prudential Financial, Inc., and certain affiliates of PGIM, Inc., provides for the issuance of up to $105,000 of Senior Secured Notes and issuance of $20,000 of Senior Secured Notes. The deadline for issuing the notes under the shelf facility is August 23, 2023. During 2017, the Company issued $20,000 of Senior Secured Notes with a maturity date of August 23, 2027. During 2019, the Company issued $20,000 of additional Senior Secured Notes with a maturity date of April 30, 2029. The Note Purchase Agreement includes certain requirements and covenants, which the Company was in compliance with at September 30, 2020.
Note 5. Income Taxes
The Company’s tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in that quarter. In each quarter, the estimated annual effective tax rate is updated and a year to date adjustment is made to the provision. The Company’s quarterly effective tax rate can be subject to significant change due to the effect of discrete items arising in a given quarter.
Income tax expense for the quarter and year to date ended September 30, 2020, was $2,862 and $8,636, respectively, for an effective tax rate of 21.6 percent and 23.1 percent, respectively. The effective tax rate for quarter to date ended September 30, 2020 differed from the 21 percent federal statutory rate on pretax income, primarily due to state taxes, partially offset by state and federal tax credits, the release of a portion of the Company's valuation allowance and the deduction applicable to export activity. The effective tax rate for year to date ended September 30, 2020, differed from the 21 percent federal statutory rate on pretax income, primarily due to state taxes, partially offset by federal and state credits, and the deduction applicable to income derived from export activity.
Income tax expense for the quarter and year to date ended September 30, 2019, was $3,025 and $4,208, respectively, for an effective tax rate of 26.9 percent and 14.0 percent, respectively. The effective tax rate for quarter ended September 30, 2019, differed from the 21 percent federal statutory rate on pretax income, primarily due to state income taxes and the discrete tax
13

impact of previously disclosed legal matters, partially offset by state and federal tax credits. The effective tax rate for year to date ended September 30, 2019, differed from the 21 percent federal statutory rate on pretax income, primarily due to the tax impact of vested share-based awards, the tax impact of state and federal tax credits, partially offset by state taxes, the discrete tax impact of previously disclosed legal matters, and certain compensation being subject to the compensation deduction limitations applicable for public companies.
In response to COVID-19, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on March 27, 2020. The CARES Act along with other guidance issued by the IRS provides for numerous tax provisions and other stimulus measures, including temporary suspension of certain payment requirements for the employer portion of Social Security taxes, deferral of income tax payments until July 15, 2020, and technical corrections from prior tax legislation. The Company is in the process of monetizing certain parts of the CARES Act, has resumed making estimated corporate income tax payments, and continues to monitor tax legislation for additional potential benefits available to the Company.
Note 6. Equity and EPS
The computations of basic and diluted EPS:

|  | Quarter Ended September 30, |  | Year to Date Ended September 30,
|  | 2020 |  | 2019 |  | 2020 |  | 2019
Operations: |  |  |  |  |  |  |  |
Net income(a) |  | $ | 10,381 |  |  | $ | 8,215 |  |  | $ | 28,713 |  |  | $ | 25,846 |
Less: Income attributable to participating securities(b) |  | 69 |  |  | 54 |  |  | 192 |  |  | 171 |
Net income attributable to common shareholders |  | $ | 10,312 |  |  | $ | 8,161 |  |  | $ | 28,521 |  |  | $ | 25,675 |
Share information: |  |  |  |  |  |  |  |
Basic and diluted weighted average common shares(c) |  | 16,916,675 |  |  | 17,027,068 |  |  | 16,943,130 |  |  | 17,006,226 |
Basic and diluted EPS |  | $ | 0.61 |  |  | $ | 0.48 |  |  | $ | 1.68 |  |  | $ | 1.51 |

(a)Net income attributable to all shareholders.
(b)Participating securities included 115,399 and 112,865 unvested restricted stock units (“RSUs”), at September 30, 2020 and 2019, respectively.
(c)Under the two-class method, basic and diluted weighted average common shares at September 30, 2020 and 2019, exclude unvested participating securities.
Share Repurchase. On February 25, 2019, MGP's Board of Directors approved a $25,000 share repurchase authorization commencing February 27, 2019, through February 27, 2022. Under the share repurchase program, the Company can repurchase stock from time to time for cash in open market purchases, block transactions, and privately negotiated transactions in accordance with applicable federal securities laws. This share repurchase program may be modified, suspended, or terminated by the Company at any time without prior notice. During year to date ended September 30, 2020, the Company repurchased approximately 159,104 shares of MGP Common Stock for $4,053, resulting in $20,947 remaining under the share repurchase plan. The shares were repurchased in multiple tranches with the final purchase concluding on March 16, 2020.
Note 7. Commitments and Contingencies
There are various legal and regulatory proceedings involving the Company and its subsidiaries. The Company accrues estimated costs for a contingency when management believes that a loss is probable and can be reasonably estimated.
In May 2020, the Company was affected by a ransomware cyber-attack that temporarily disrupted production at its Atchison facilities. The Company's financial information was not affected and there is no evidence that any sensitive or confidential company, supplier, customer or employee data was improperly accessed or extracted from our network. The Company estimates that the ransomware attack adversely impacted gross profit by $1,728, primarily as a result of the business interruption. The Company has insurance related to this event and is seeking to recover a portion, if not all, of any profit impact including the profit associated with any loss of revenue resulting from this event. The Company will record insurance recovery when it is probable of collection. Following the attack, MGP implemented a variety of measures to further enhance our
14

cybersecurity protections and minimize the impact of any future attack.
In 2020, two putative class action lawsuits were filed in the United States District Court for District of Kansas, naming the Company and certain of its current and former executive officers as defendants, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The plaintiffs seek to pursue claims on behalf of a class consisting of purchasers or acquirers of the Company's Common Stock during certain specified periods (the “Class Periods”). On May 28, 2020, the two lawsuits were consolidated and the Court appointed City of Miami Fire Fighters’ and Police Officers’ Retirement Trust as lead plaintiff. The consolidated action is captioned In re MGP Ingredients, Inc. Securities Litigation and the file is maintained under Master File No. 2:20-cv-2090-DDCJPO. On July 22, 2020, the Retirement Trust filed a consolidated Amended Complaint. The Consolidated Complaint alleges that the defendants made false and/or misleading statements regarding the Company’s forecasts of sales of aged whiskey, and that, as a result the Company's Common Stock traded at artificially inflated prices throughout the Class Periods. The plaintiffs seek compensatory damages, interest, attorneys’ fees, costs, and unspecified equitable relief, but have not specified the amount of damages being sought. On September 8, 2020, defendants filed a Motion to Dismiss the Consolidated Amended Complaint. The Motion is pending. The Company intends to continue to vigorously defend itself in this action.
On May 11, 2020, Mitchell Dorfman, a shareholder in MGP, filed an action in the United States District Court for the District of Kansas, under the caption Dorfman, derivatively on behalf of MGP Ingredients v. Griffin, et al., Case 2:20-cv-02239. On June 4, 2020, Justin Carter, a shareholder in MGP, filed an action in the United States District Court for the District of Kansas, under the caption Carter, derivatively on behalf of MGP Ingredients v. Griffin, et al., Case 2:20-cv-02281. On June 18, 2020, Alexandra Kearns, a shareholder in MGP, filed an action in the District Court of Atchison County, Kansas, under the caption Kearns, derivatively on behalf of MGP Ingredients v. Griffin, et al., Case 2020-CV-000042. The defendants are certain of the Company’s current and former officers and directors. The Company is a nominal defendant in each action. Plaintiffs allege that the Company was damaged as a result of the conduct of the individual defendants alleged in the MGP Ingredients, Inc. Securities Litigation, the repurchase of company stock at artificially inflated prices, and compensation paid to the individual defendants. The Complaint in Dorfman asserts claims for violations of Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, breach of fiduciary duties, waste of corporate assets, and unjust enrichment. The Complaint in Carter asserts claims for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, breach of fiduciary duties, waste of corporate assets, and unjust enrichment. The Petition in Kearns asserts claims for breach of fiduciary duties, waste of corporate assets, and unjust enrichment. The pleadings pray for an award of compensatory damages, including interest, in favor of the Company, for equitable relief related to the Company’s corporate governance, for disgorgement of compensation, and for an award of attorneys’ fees and costs. On July 13, 2020, defendants filed a Motion to Dismiss in Dorfman. The Motion is pending. On August 13, 2020, defendants filed a Motion to Stay the Kearns action pending the resolution of Dorfman. The Motion is pending.
A chemical release occurred at the Company’s Atchison facility on October 21, 2016, which resulted in emissions venting into the air (“the Atchison Chemical Release”). The Company reported the event to the Environmental Protection Agency (“EPA”), the Occupational Safety and Health Administration (“OSHA”), and to Kansas and local authorities on that date, and has cooperated fully to investigate and ensure that all appropriate response actions were taken.
On May 29, 2019, federal charges for alleged violations of the Clean Air Act related to the Atchison Chemical Release were filed against the Company, along with another unaffiliated company. The Company and the Department of Justice resolved the allegations through a Plea Agreement entered with the Court on November 18, 2019, pursuant to which the Company agreed, among other things, to plead guilty to a misdemeanor negligent violation of the Clean Air Act and pay a fine of $1,000. On May 27, 2020, the Court accepted the Plea Agreement and sentenced the Company to pay a fine of $1,000 consistent with the terms of the parties’ resolution. The fine has been paid and the matter is terminated.
Private plaintiffs have also initiated, and additional private plaintiffs may initiate, legal proceedings for damages resulting from the Atchison Chemical Release, but the Company is currently unable to reasonably estimate the amount of any such damages that might result. The Company’s insurance is expected to provide coverage of any damages to private plaintiffs, subject to a deductible of $250, but certain regulatory fines or penalties may not be covered and there can be no assurance to the amount or timing of possible insurance recoveries if ultimately claimed by the Company.
Note 8. Employee and Non-Employee Benefit Plans
Equity-Based Compensation Plans. The Company’s equity-based compensation plans provide for the awarding of stock options, stock appreciation rights, shares of restricted stock (“Restricted Stock”), and RSUs for senior executives and salaried employees, as well as non-employee directors. The Company has two active equity-based compensation plans: the Employee Equity Incentive Plan of 2014 (the “2014 Plan”) and the Non-Employee Director Equity Incentive Plan (the “Directors’ Plan”).
15

As of September 30, 2020, 421,220 RSUs had been granted of the 1,500,000 shares approved under the 2014 Plan, and 107,622 shares had been granted of the 300,000 shares approved under the Directors’ Plan. As of September 30, 2020, there were 123,439 unvested RSUs under the Company’s long-term incentive plans and 115,399 were participating securities (Note 6).
Deferred Compensation Plan. The Company established an unfunded Executive Deferred Compensation Plan (“EDC Plan”) effective as of June 30, 2018, with a purpose to attract and retain highly-compensated key employees by providing participants with an opportunity to defer receipt of a portion of their salary, bonus, and other specified compensation. The Company’s obligations under this plan will change in conjunction with the performance of the participants’ investments, along with contributions to and withdrawals from the plan. Realized and unrealized gains (losses) on deferred compensation plan investments were included as a component of Interest expense, net and other in the Company’s Condensed Consolidated Statements of Income for the quarter ended September 30, 2020. For quarter and year to date ended September 30, 2020, the Company had a gain on deferred compensation plan investments of $185 and $352, respectively. For quarter ended September 30, 2019, the Company had a loss on deferred compensation plan investments of $30 and for year to date ended September 30, 2019 a gain on deferred compensation plan investments of $50.
Plan investments are classified as Level 1 in the fair value hierarchy since the investments trade with sufficient frequency and volume to enable the Company to obtain pricing information on an ongoing basis. Participants were able to direct the deferral of a portion of their base salary and a portion of their estimated accrued Short-term incentive plan (“STI Plan”) amounts that were paid during first quarter of the following year. Base salary amounts elected for deferral are deposited into the EDC Plan by the Company on a weekly basis and allocated by participants among Company-determined investment options. STI plan deferral were deposited, at the time of payment, into the EDC Plan by the Company and allocated by participants among Company-determined investment options.
At September 30, 2020 and December 31, 2019, the EDC Plan investments were $1,707 and $1,185, respectively, which were recorded in Other assets on the Company’s Condensed Consolidated Balance Sheets. The EDC Plan non-current liabilities were $2,222 and $1,337 at September 30, 2020 and December 31, 2019, respectively, and were included in Other noncurrent liabilities on the Company’s Condensed Consolidated Balance Sheets.
Note 9. Operating Segments
At September 30, 2020 and 2019, the Company had two segments: Distillery Products and Ingredient Solutions. The Distillery Products segment consists of food grade alcohol and distillery co-products, such as distillers feed (commonly called dried distillers grain in the industry) and fuel grade alcohol. The Distillery Products segment also includes warehouse services, including barrel put away, storage, retrieval, and blending services. Ingredient Solutions segment consists of specialty starches and proteins and commodity starches and proteins.
Operating profit for each segment is based on sales less identifiable operating expenses. Non-direct selling, general and administrative expenses, interest expense, other special charges, and other general miscellaneous expenses are excluded from segment operations and are classified as Corporate. Receivables, inventories, and equipment have been identified with the segments to which they relate. All other assets are considered as Corporate.
16

|  | Quarter Ended September 30, |  | Year to Date Ended September 30,
|  | 2020 |  | 2019 |  | 2020 |  | 2019
Sales to Customers |  |  |  |  |  |  |  |
Distillery Products |  | $ | 81,622 |  |  | $ | 73,295 |  |  | $ | 236,813 |  |  | $ | 221,895 |
Ingredient Solutions |  | 21,342 |  |  | 17,390 |  |  | 57,793 |  |  | 48,387 |
Total |  | $ | 102,964 |  |  | $ | 90,685 |  |  | $ | 294,606 |  |  | $ | 270,282 |
Gross Profit |  |  |  |  |  |  |  |
Distillery Products |  | $ | 17,307 |  |  | $ | 15,905 |  |  | $ | 51,559 |  |  | $ | 47,647 |
Ingredient Solutions |  | 5,855 |  |  | 2,885 |  |  | 15,516 |  |  | 7,325 |
Total |  | $ | 23,162 |  |  | $ | 18,790 |  |  | $ | 67,075 |  |  | $ | 54,972 |
Depreciation and Amortization |  |  |  |  |  |  |  |
Distillery Products |  | $ | 2,491 |  |  | $ | 2,274 |  |  | $ | 7,339 |  |  | $ | 6,628 |
Ingredient Solutions |  | 480 |  |  | 384 |  |  | 1,402 |  |  | 1,123 |
Corporate |  | 303 |  |  | 277 |  |  | 877 |  |  | 786 |
Total |  | $ | 3,274 |  |  | $ | 2,935 |  |  | $ | 9,618 |  |  | $ | 8,537 |
Income (loss) before Income Taxes |  |  |  |  |  |  |  |
Distillery Products |  | $ | 15,707 |  |  | $ | 14,180 |  |  | $ | 46,374 |  |  | $ | 42,481 |
Ingredient Solutions |  | 5,191 |  |  | 2,226 |  |  | 13,504 |  |  | 5,326 |
Corporate |  | (7,655) |  |  | (5,166) |  |  | (22,529) |  |  | (17,753) |
Total |  | $ | 13,243 |  |  | $ | 11,240 |  |  | $ | 37,349 |  |  | $ | 30,054 |

The following table allocates assets to each segment as of:

|  | September 30, 2020 |  | December 31, 2019
Identifiable Assets |  |  |  |
Distillery Products |  | $ | 282,504 |  |  | $ | 271,766 |
Ingredient Solutions |  | 40,442 |  |  | 30,802 |
Corporate |  | 38,800 |  |  | 20,029 |
Total |  | $ | 361,746 |  |  | $ | 322,597 |

Note 10. Subsequent Events
Dividend. On October 27, 2020, the Company’s Board of Directors declared a quarterly dividend payable to stockholders of record as of November 20, 2020, of the Company’s Common Stock, and a dividend equivalent payable to holders of certain RSUs as of November 20, 2020, of $0.12 per share and per unit, payable on December 4, 2020.
17

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollar amounts in thousands, unless otherwise noted)
CAUTIONARY NOTE CONCERNING FACTORS THAT MAY AFFECT FUTURE RESULTS
This Report on Form 10-Q contains forward looking statements as well as historical information. All statements, other than statements of historical facts, regarding the prospects of our industry and our prospects, plans, financial position, and strategic plan may constitute forward looking statements. In addition, forward looking statements are usually identified by or are associated with such words as “intend,” “plan,” “believe,” “estimate,” “expect,” “anticipate,” “hopeful,” “should,” “may,” “will,” “could,” “encouraged,” “opportunities,” “potential,” and/or the negatives or variations of these terms or similar terminology. Forward looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from those expressed or implied in the forward looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward looking statements is included in the section titled “Risk Factors” (Item 1A) of our Annual Report on Form 10-K for the year ended December 31, 2019 and Part II, Item 1A of this report Form 10Q. Forward looking statements are made as of the date of this report, and we undertake no obligation to update or revise publicly any forward looking statements, whether because of new information, future events or otherwise.
On March 11, 2020, the World Health Organization classified the novel strain of coronavirus ("COVID-19") a global pandemic. The Company's business is part of the United States' critical infrastructure and thus is deemed to be an "essential business." As such, MGP is taking necessary and appropriate actions to protect its workforce as it continues its critical operations. MGP has created a COVID-19 cross functional team to implement a business continuity plan and address key aspects of COVID-19 as it affects its business, including enhanced workplace safety, supply chain monitoring, and other potential operational challenges the Company could face. We have continued to operate without any significant negative impacts; however this could be effected by voluntary or mandatory temporary closures of our facilities, interruptions to our supply chain or additional efforts to protect the health and safety of our employees.
As of the date of this report, the Company's operations, supply chain and customer demand have not been significantly affected by COVID-19; however, we are monitoring the situation closely. The Company has implemented social distancing at each of its facilities, provides health screenings and monitoring for employees, implemented work-from-home policies where the Company is able, and restricted travel across the organization. The Company has incurred incremental costs for hourly wage bonuses to the Company's production employees, supplies to implement health screenings, an extended sick leave policy and additional IT related expenses to enable employees to work-from-home. As of September 30, 2020, such incremental costs have been immaterial to the Company's financial statements. The Company cannot reasonably estimate the length of time or severity of the pandemic and cannot estimate the impact this pandemic will have on our consolidated financial results for 2020. See Risk Factors for future discussion of the potential adverse impacts of the COVID-19 pandemic on our business.
In May 2020, the Company was affected by a ransomware cyber-attack that temporarily disrupted production at its Atchison facilities. The Company's financial information was not affected and there is no evidence that any sensitive or confidential company, supplier, customer or employee data was improperly accessed or extracted from our network. The Company estimates that the ransomware attack adversely impacted gross profit by $1,728, primarily as a result of the business interruption. The Company has insurance related to this event and is seeking to recover a portion, if not all, of any profit impact including the profit associated with any loss of revenue resulting from this event. Following the attack, MGP implemented a variety of measures to further enhance our cybersecurity protections and minimize the impact of any future attack.
OVERVIEW
MGP is a leading producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. Distilled spirits include premium bourbon and rye whiskeys and grain neutral spirits (“GNS”), including vodka and gin. We are also a top producer of high quality industrial alcohol for use in both food and non-food applications. Our protein and starch food ingredients provide a host of functional, nutritional and sensory benefits for a wide range of food products to serve the packaged goods industry. We have two reportable segments: our Distillery Products segment and our Ingredient Solutions segment.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and accompanying notes included in this Form 10-Q, as well as our audited consolidated financial statements and accompanying notes and Management’s Discussion and Analysis of Financial
18

Condition and Results of Operations - General, set forth in our Annual Report on Form 10-K for the year ended December 31, 2019.
RESULTS OF OPERATIONS
Consolidated results
The table below details the consolidated results for the quarters ended September 30, 2020 and 2019:

| Quarter Ended September 30, |  |  |  |  |
| 2020 |  | 2019 |  |  |  | 2020 v. 2019 |
Sales | $ | 102,964 |  |  | $ | 90,685 |  |  |  |  | 13.5 | % |
Cost of sales | 79,802 |  |  | 71,895 |  |  |  |  | 11.0 |  |
Gross profit | 23,162 |  |  | 18,790 |  |  |  |  | 23.3 |  |
Gross margin % | 22.5 | % |  | 20.7 | % |  |  |  | 1.8 |  | pp(a)
Selling, general, and administrative (“SG&A”) expenses | 9,510 |  |  | 7,186 |  |  |  |  | 32.3 |  |
Operating income | 13,652 |  |  | 11,604 |  |  |  |  | 17.7 |  |
Operating margin % | 13.3 | % |  | 12.8 | % |  |  |  | 0.5 |  | pp
Interest expense, net and other | (409) |  |  | (364) |  |  |  |  | 12.4 |  |
Income before income taxes | 13,243 |  |  | 11,240 |  |  |  |  | 17.8 |  |
Income tax expense | 2,862 |  |  | 3,025 |  |  |  |  | (5.4) |  |
Effective tax expense rate % | 21.6 | % |  | 26.9 | % |  |  |  | (5.3) |  | pp
Net income | $ | 10,381 |  |  | $ | 8,215 |  |  |  |  | 26.4 | % |
Net income margin % | 10.1 | % |  | 9.1 | % |  |  |  | 1.0 |  | pp

(a) Percentage points (“pp”).
Sales - Sales for quarter ended September 30, 2020 were $102,964, an increase of 13.5 percent compared to the year-ago quarter, which was the result of increased sales in both the Distillery Products and Ingredient Solutions segments. Within the Distillery Products segment, sales were up 11.4 percent, primarily due to an increase in the sales of brown goods and white goods within premium beverage alcohol. Within the Ingredient Solutions segment, sales were up 22.7 percent, primarily due to increased sales of specialty wheat starches and proteins (see Segment Results).
Gross profit - Gross profit for quarter ended September 30, 2020 was $23,162, an increase of 23.3 percent compared to the year-ago quarter. The increase was driven by an increase in gross profit in both the Ingredient Solutions and Distillery Products segment. In the Ingredient Solutions segment, gross profit increased by $2,970, or 102.9 percent. In the Distillery Products segment, gross profit increased by $1,402, or 8.8 percent. (see Segment Results).
SG&A expenses - SG&A expenses for quarter ended September 30, 2020 were $9,510, an increase of 32.3 percent compared to the year-ago quarter. The increase in SG&A was primarily due to higher incentive compensation expense and professional service fees, partially offset by decreased costs related to the EPA settlement discussed in Note 7.
Operating income - Operating income for quarter ended September 30, 2020 increased to $13,652 from $11,604 for quarter ended September 30, 2019, primarily due to an increase in gross profit in both the Ingredient Solutions and Distillery Products segment, partially offset by the increase in the previously described SG&A expenses.
19

Operating income, quarter versus quarter |  | Operating Income |  | Change |
Operating income for quarter ended September 30, 2019 |  | $ | 11,604 |  |  |  |
Increase in gross profit - Ingredient Solutions segment(a) |  | 2,970 |  |  | 25.6 |  | pp(b)
Increase in gross profit - Distillery Products segment(a) |  | 1,402 |  |  | 12.1 |  | pp
Increase in SG&A expenses |  | (2,324) |  |  | (20.0) |  | pp
Operating income for quarter ended September 30, 2020 |  | $ | 13,652 |  |  | 17.7 | % |

(a) See segment discussion.
(b) Percentage points (“pp”).
Income tax expense - Income tax expense for quarter ended September 30, 2020 was $2,862, for an effective tax rate of 21.6 percent. Income tax expense for the quarter ended September 30, 2019, was $3,025, for an effective tax rate of 26.9 percent. The decrease, quarter versus quarter, was primarily due to the release of a portion of the Company's valuation allowance.
Earnings per share (“EPS”) - EPS was $0.61 for quarter ended September 30, 2020, compared to $0.48 for quarter ended September 30, 2019. The change in EPS, quarter versus quarter, was primarily due to an increase in operations, and by a change in income tax expense as previously described.

Change in basic and diluted EPS, quarter versus quarter |  | Basic and Diluted EPS |  | Change |  |  |  |  |
Basic and diluted EPS for quarter ended September 30, 2019 |  | $ | 0.48 |  |  |  |  |  |  |  |
Increase in operations(a) |  | 0.09 |  |  | 18.8 |  | pp(b) |  |  |  |
Tax: Change in income tax |  | 0.03 |  |  | 6.3 |  | pp |  |  |  |
Decrease in weighted average shares outstanding |  | 0.01 |  |  | 2.1 |  | pp |  |  |  |
Basic and diluted EPS for quarter ended September 30, 2020 |  | $ | 0.61 |  |  | 27.2 | % |  |  |  |  |

(a) Item is net of tax based on the effective tax rate for the base year (2019).
(b) Percentage points (“pp”).
The table below details the consolidated results for the year to date ended September 30, 2020 and 2019:

| Year to Date Ended September 30, |  |  |  |
| 2020 |  | 2019 |  |  |  | 2020 v. 2019 |
Sales | $ | 294,606 |  |  | $ | 270,282 |  |  |  |  | 9.0 | % |
Cost of sales | 227,531 |  |  | 215,310 |  |  |  |  | 5.7 |  |
Gross profit | 67,075 |  |  | 54,972 |  |  |  |  | 22.0 |  |
Gross margin % | 22.8 | % |  | 20.3 | % |  |  |  | 2.5 |  | pp(a)
SG&A expenses | 28,377 |  |  | 23,981 |  |  |  |  | 18.3 |  |
Operating income | 38,698 |  |  | 30,991 |  |  |  |  | 24.9 |  |
Operating margin % | 13.1 | % |  | 11.5 | % |  |  |  | 1.6 |  | pp
Interest expense, net and other | (1,349) |  |  | (937) |  |  |  |  | 44.0 |  |
Income before income taxes | 37,349 |  |  | 30,054 |  |  |  |  | 24.3 |  |
Income tax expense | 8,636 |  |  | 4,208 |  |  |  |  | 105.2 |  |
Effective tax expense rate % | 23.1 | % |  | 14.0 | % |  |  |  | 9.1 |  | pp
Net income | $ | 28,713 |  |  | $ | 25,846 |  |  |  |  | 11.1 | % |
Net income margin % | 9.7 | % |  | 9.6 | % |  |  |  | 0.1 |  | pp

(a) Percentage points (“pp”).
Sales - Sales for year to date ended September 30, 2020 were $294,606, an increase of 9.0 percent compared to the year-ago period, which was the result of increased sales in both the Distillery Products and Ingredient Solutions segments. Within the Distillery Products segment, sales were up 6.7 percent, primarily due to an increase in the sales of brown goods within premium beverage alcohol, industrial alcohol, white goods within premium beverage alcohol, and warehouse services. Within the Ingredient Solutions segment, sales were up 19.4 percent, primarily due to increased sales of specialty wheat starches and proteins (see Segment Results).
20

Gross profit - Gross profit for year to date ended September 30, 2020 was $67,075, an increase of 22.0 percent compared to the year-ago period. The increase was driven by an increase in gross profit in both the Ingredient Solutions and Distillery Products segments. In the Ingredient Solutions segment, gross profit increased by $8,191, or 111.8 percent. In the Distillery Products segment, gross profit increase by $3,912, or 8.2 percent. Additionally, gross profits for both segments were negatively impacted by increased production costs due to the shutdown of the Atchison facilities as a result of the cyber-attack (see Segment Results).
SG&A expenses - SG&A expenses for year to date ended September 30, 2020 were $28,377, an increase of 18.3 percent compared to the year-ago period. The increase in SG&A was due to higher personnel and incentive compensation costs, inclusive of certain incremental costs incurred relating to the transition at the CEO position.
Operating income - Operating income for year to date ended September 30, 2020 increased to $38,698 from $30,991 for year to date period ended September 30, 2019, primarily due to a increase in gross profit in both the Ingredient Solutions and Distillery Products segments. These increases were partially offset by an increase in the above-described SG&A expenses.

Operating income, year to date versus year to date |  | Operating Income |  | Change |
Operating income for year to date ended September 30, 2019 |  | $ | 30,991 |  |  |  |
Increase in gross profit - Ingredient Solutions segment(a) |  | 8,191 |  |  | 26.4 |  | pp(b)
Increase in gross profit - Distillery Products segment(a) |  | 3,912 |  |  | 12.6 |  | pp
Increase in SG&A expenses |  | (4,396) |  |  | (14.1) |  | pp
Operating income for year to date ended September 30, 2020 |  | $ | 38,698 |  |  | 24.9 | % |

(a) See segment discussion.
(b) Percentage points (“pp”).
Income tax expense - Income tax expense for year to date ended September 30, 2020 was $8,636, for an effective tax rate of 23.1 percent. Income tax expense for the year to date ended September 30, 2019, was $4,208, for an effective tax rate of 14.0 percent. The increase, year to date versus year to date, was primarily due to the tax benefit of vested share-based awards realized in the prior year.
Earnings per share - EPS was $1.68 for year to date ended September 30, 2020, compared to $1.51 for year to date ended September 30, 2019. EPS increased, year to date versus year to date, primarily due to an increase in operations, partially offset by a change in income tax expense as previously described.

Change in basic and diluted EPS, year to date versus year to date |  | Basic and Diluted EPS |  | Change |
Basic and diluted EPS for year to date ended September 30, 2019 |  | $ | 1.51 |  |  |  |
Increase in operations(a) |  | 0.47 |  |  | 31.1 |  | pp(b)
Decrease in weighted average shares outstanding |  | 0.02 |  |  | 1.3 |  | pp
Change in interest expense, net(a) |  | (0.03) |  |  | (2.0) |  | pp
Tax: Change in share-based compensation |  | (0.21) |  |  | (13.9) |  | pp
Tax: Change in effective tax rate (excluding above tax item) |  | (0.08) |  |  | (5.3) |  | pp
Basic and diluted EPS for year to date ended September 30, 2020 |  | $ | 1.68 |  |  | 11.2 | % |

(a) Item is net of tax based on the effective tax rate for the base year (2019).
(b) Percentage points (“pp”).
21

SEGMENT RESULTS
Distillery Products
The following tables show selected financial information for the Distillery Products segment for the quarters ended September 30, 2020 and 2019.

| DISTILLERY PRODUCTS SALES |
| Quarter Ended September 30, |  | Quarter versus Quarter Sales Change Increase/(Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Brown goods | $ | 34,365 |  |  | $ | 26,606 |  |  | $ | 7,759 |  |  | 29.2 | % |
White goods | 16,362 |  |  | 15,359 |  |  | 1,003 |  |  | 6.5 |  |
Premium beverage alcohol | 50,727 |  |  | 41,965 |  |  | 8,762 |  |  | 20.9 |  |
Industrial alcohol | 19,461 |  |  | 19,525 |  |  | (64) |  |  | (0.3) |  |
Food grade alcohol | 70,188 |  |  | 61,490 |  |  | 8,698 |  |  | 14.1 |  |
Fuel grade alcohol | 1,274 |  |  | 1,438 |  |  | (164) |  |  | (11.4) |  |
Distillers feed and related co-products | 6,119 |  |  | 6,630 |  |  | (511) |  |  | (7.7) |  |
Warehouse services | 4,041 |  |  | 3,737 |  |  | 304 |  |  | 8.1 |  |
Total Distillery Products | $ | 81,622 |  |  | $ | 73,295 |  |  | $ | 8,327 |  |  | 11.4 | % |
| Change in Quarter versus Quarter Sales Attributed to: |  |  |
| Total (a) |  | Volume(b) |  | Net Price/Mix(c) |  |  |
Premium beverage alcohol | 20.9% |  | 25.7% |  | (4.8)% |  |  |
| Other Financial Information |
| Quarter Ended September 30, |  | Quarter versus Quarter Increase / (Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Gross profit | $ | 17,307 |  |  | $ | 15,905 |  |  | $ | 1,402 |  |  | 8.8 | % |
Gross margin % | 21.2 | % |  | 21.7 | % |  |  |  | (0.5) |  | pp(d)

(a) Total sales changes is calculated by taking the difference between current period sales dollars and prior period sales dollars, divided by prior period sales dollars.
(b) Volume change is calculated by taking the difference between current period sales volume and prior period sales volume, multiplied by prior period sales per unit
(c) Price/Mix change is calculated by taking the difference between current period sales-per-unit and prior period sales-per unit, multiplied by current period sales volume.
(d) Percentage points (“pp”).
Total sales of Distillery Products for the quarter ended September 30, 2020 increased by $8,327, or 11.4 percent, compared to the prior year quarter. Sales of brown goods and white goods within premium beverage alcohol and warehouse services increased while distillers feed and related co-products, fuel grade alcohol and industrial alcohol decreased compared to the prior year quarter. The increase in sales of brown goods was driven by higher sales volume partially offset by lower average selling price. The increase in white goods was driven by higher sales volume and favorable average selling price. These increases were slightly offset by a decrease in distillers feed and related co-products and fuel grade alcohol which were driven by lower average selling price and lower sales volumes. The slight decrease in sales of industrial alcohol was driven by lower sales volume, partially offset by higher sales price.
Gross profit increased quarter versus quarter by $1,402, or 8.8 percent. Gross margin for the quarter ended September 30, 2020 decreased to 21.2 percent from 21.7 percent for the prior year quarter. The increase in gross profit was primarily due to higher sales volume on brown goods as well as decreased input costs and favorable average selling price on industrial alcohol. The increase in gross profit was partially offset by higher costs relating to a reduction in brown goods put-away for aging during the quarter, lower average selling price on brown goods and higher input costs of white goods, as well as lower average selling price and lower sales volume on distillers feed and related co-products.
22

The following tables show selected financial information for the Distillery Products segment for the year to date ended September 30, 2020 and 2019.

| DISTILLERY PRODUCTS SALES |
| Year to Date Ended September 30, |  | Year to Date versus Year to Date Sales Change Increase/(Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Brown Goods | $ | 88,975 |  |  | $ | 79,054 |  |  | $ | 9,921 |  |  | 12.5 | % |
White Goods | 48,306 |  |  | 47,232 |  |  | 1,074 |  |  | 2.3 |  |
Premium beverage alcohol | 137,281 |  |  | 126,286 |  |  | 10,995 |  |  | 8.7 |  |
Industrial alcohol | 64,032 |  |  | 60,604 |  |  | 3,428 |  |  | 5.7 |  |
Food grade alcohol | 201,313 |  |  | 186,890 |  |  | 14,423 |  |  | 7.7 |  |
Fuel grade alcohol | 3,970 |  |  | 4,337 |  |  | (367) |  |  | (8.5) |  |
Distillers feed and related co-products | 19,889 |  |  | 19,906 |  |  | (17) |  |  | (0.1) |  |
Warehouse services | 11,641 |  |  | 10,762 |  |  | 879 |  |  | 8.2 |  |
Total Distillery Products | $ | 236,813 |  |  | $ | 221,895 |  |  | $ | 14,918 |  |  | 6.7 | % |
| Change in Year to Date versus Year to Date Sales Attributed to: |  |  |
| Total(a) |  | Volume(b) |  | Net Price/Mix(c) |  |  |
Premium beverage alcohol | 8.7% |  | 11.1% |  | (2.4)% |  |  |
| Other Financial Information |
| Year to Date Ended September 30, |  | Year to Date versus Year to Date Increase / (Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Gross profit | $ | 51,559 |  |  | $ | 47,647 |  |  | $ | 3,912 |  |  | 8.2 | % |
Gross margin % | 21.8 | % |  | 21.5 | % |  |  |  | 0.3 |  | pp(d)

(a) Total sales changes is calculated by taking the difference between current period sales dollars and prior period sales dollars, divided by prior period sales dollars.
(b) Volume change is calculated by taking the difference between current period sales volume and prior period sales volume, multiplied by prior period sales per unit
(c) Price/Mix change is calculated by taking the difference between current period sales-per-unit and prior period sales-per unit, multiplied by current period sales volume.
(d) Percentage points (“pp”).
Total sales of Distillery Products for year to date ended September 30, 2020 increased by $14,918, or 6.7 percent compared to the year-ago period. Sales of brown goods within premium beverage alcohol, industrial alcohol, white goods within premium beverage alcohol, and warehouse services increased, while sales of fuel grade alcohol and distillers feed and related co-products decreased compared to the year-ago period. The increase in brown goods was due to increased sales volume, partially offset by a decrease in average selling price. The increase in industrial alcohol and white goods was due to increased sales volume and favorable average selling price. These increases were partially offset by lost potential sales volume due to the shutdown of the Atchison facilities as a result of the cyber-attack.
Gross profit for year to date ended September 30, 2020 increased by $3,912, or 8.2 percent compared to the year-ago period. Gross margin for year to date ended September 30, 2020 increased to 21.8 percent from 21.5 percent for the prior year period. The increase in gross profit was primarily due to higher sales volumes on brown goods and favorable average selling price on industrial alcohol and white goods. The increase in gross profit was partially offset by higher costs relating to a reduction in brown goods put-away for aging, lower average selling price on brown goods, and increased production costs due to the shutdown of the Atchison facilities as a result of the cyber-attack.
23

Ingredient Solutions
The following tables show selected financial information for the Ingredient Solutions segment for the quarter ended September 30, 2020 and 2019.

| INGREDIENT SOLUTIONS SALES |
| Quarter Ended September 30, |  | Quarter versus Quarter Sales Change Increase / (Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Specialty wheat starches | $ | 11,604 |  |  | $ | 8,432 |  |  | $ | 3,172 |  |  | 37.6 | % |
Specialty wheat proteins | 7,994 |  |  | 6,166 |  |  | 1,828 |  |  | 29.6 |  |
Commodity wheat starches | 1,596 |  |  | 2,300 |  |  | (704) |  |  | (30.6) |  |
Commodity wheat proteins | 148 |  |  | 492 |  |  | (344) |  |  | (69.9) |  |
Total Ingredient Solutions | $ | 21,342 |  |  | $ | 17,390 |  |  | $ | 3,952 |  |  | 22.7 | % |
| Change in Quarter versus Quarter Sales Attributed to: |  |  |
| Total(a) |  | Volume(b) |  | Net Price/Mix(c) |  |  |
Total Ingredient Solutions | 22.7% |  | 10.2% |  | 12.5% |  |  |
| Other Financial Information |
| Quarter Ended September 30, |  | Quarter versus Quarter Increase / (Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Gross profit | $ | 5,855 |  |  | $ | 2,885 |  |  | $ | 2,970 |  |  | 102.9 | % |
Gross margin % | 27.4 | % |  | 16.6 | % |  |  |  | 10.8 |  | pp(d)

(a) Total sales changes is calculated by taking the difference between current period sales dollars and prior period sales dollars, divided by prior period sales dollars.
(b) Volume change is calculated by taking the difference between current period sales volume and prior period sales volume, multiplied by prior period sales per unit
(c) Price/Mix change is calculated by taking the difference between current period sales-per-unit and prior period sales-per unit, multiplied by current period sales volume.
(d) Percentage points (“pp”).
Total Ingredient Solutions sales for quarter ended September 30, 2020 increased by $3,952, or 22.7 percent, compared to the prior year quarter. Quarter versus quarter, this increase was driven by higher sales of specialty wheat starches and proteins, partially offset by a decrease in sales of commodity wheat starches and proteins. The increase in sales of specialty wheat starches and proteins was primarily driven by increased sales volume. These increases were partially offset by decreased sales volume of commodity wheat starches and proteins.
Gross profit increased quarter versus quarter by $2,970, or 102.9 percent. Gross margin for the quarter ended September 30, 2020 increased to 27.4 percent from 16.6 percent for the prior year quarter. The increase in gross profit was primarily driven by the increased sales volume of specialty wheat starches and proteins and decreased sales volume of commodity wheat starches and proteins (mix). Additionally, gross profit was positively impacted by the optimization of higher margin specialty products to meet the increased demand of customers' high fiber and high protein products.
24

The following tables show selected financial information for the Ingredient Solutions segment for the year to date September 30, 2020 and 2019.

| INGREDIENT SOLUTIONS SALES |
| Year to Date Ended September 30, |  | Year to Date versus Year to Date Sales Change Increase/(Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Specialty wheat starches | $ | 30,938 |  |  | $ | 22,523 |  |  | $ | 8,415 |  |  | 37.4 | % |
Specialty wheat proteins | 20,372 |  |  | 15,884 |  |  | 4,488 |  |  | 28.3 |  |
Commodity wheat starches | 5,247 |  |  | 7,575 |  |  | (2,328) |  |  | (30.7) |  |
Commodity wheat proteins | 1,236 |  |  | 2,405 |  |  | (1,169) |  |  | (48.6) |  |
Total Ingredient Solutions | $ | 57,793 |  |  | $ | 48,387 |  |  | $ | 9,406 |  |  | 19.4 | % |
| Change in Year to Date versus Year to Date Sales Attributed to: |  |  |
| Total(a) |  | Volume(b) |  | Net Price/Mix(c) |  |  |
Total Ingredient Solutions | 19.4% |  | 5.3% |  | 14.1% |  |  |
| Other Financial Information |
| Year to Date Ended September 30, |  | Year to Date versus Year to Date Increase / (Decrease) |
| 2020 |  | 2019 |  | $ Change |  | % Change |
Gross profit | $ | 15,516 |  |  | $ | 7,325 |  |  | $ | 8,191 |  |  | 111.8 | % |
Gross margin % | 26.8 | % |  | 15.1 | % |  |  |  | 11.7 |  | pp(d)

(a) Total sales changes is calculated by taking the difference between current period sales dollars and prior period sales dollars, divided by prior period sales dollars.
(b) Volume change is calculated by taking the difference between current period sales volume and prior period sales volume, multiplied by prior period sales per unit
(c) Price/Mix change is calculated by taking the difference between current period sales-per-unit and prior period sales-per unit, multiplied by current period sales volume.
(d) Percentage points (“pp”).
Total Ingredient Solutions sales for year to date ended September 30, 2020 increased by $9,406, or 19.4 percent, compared to the prior year period. The increase in Ingredient Solutions sales was driven by higher sales of specialty wheat starches and proteins, partially offset by a decrease in sales of commodity wheat starches and proteins. The increase in sales of specialty wheat starches was driven by increased sales volume and favorable average selling prices. The increase in sales of specialty wheat proteins was driven by increased sales volume, partially offset by unfavorable average selling prices. These increases were partially offset by decreased sales volume of commodity wheat starches and proteins, and by lost potential sales volume due to the shutdown of the Atchison facilities as a result of the cyber-attack.
Gross profit increased by $8,191, or 111.8 percent for year to date ended September 30, 2020 compared to the prior year period. Gross margin for the year to date ended September 30, 2020 increased to 26.8 percent from 15.1 percent for the prior year period. The increase in gross profit was primarily driven by the increased sales volume and favorable average selling prices of specialty wheat starches and proteins and decreased sales volume of commodity wheat starches and proteins (mix). Additionally, gross profit was positively impacted by the optimization of higher margin specialty products to meet the increased demand of customers' high fiber and high protein products. These increases in gross profit were offset by increased production costs due to the shutdown of the Atchison facilities as a result of the cyber-attack.
25

CASH FLOW, FINANCIAL CONDITION AND LIQUIDITY
We believe our financial condition continues to be of high quality, as evidenced by our ability to generate adequate cash from operations while having ready access to capital at competitive rates.
Operating cash flow and debt through our Credit Agreement and Note Purchase Agreement (Note 4) provide the primary sources of cash to fund operating needs and capital expenditures. These same sources of cash are used to fund shareholder dividends and other discretionary uses. Going forward, we expect to use cash to implement our invest to grow strategy, particularly in the Distillery Products segment. Our overall liquidity reflects our strong business results and an effective cash management strategy that takes into account liquidity management, economic factors, and tax considerations. We expect our sources of cash, including our Credit Agreement and Note Purchase Agreement, to be adequate to provide for budgeted capital expenditures and anticipated operating requirements for the foreseeable future.
Cash Flow Summary

|  | Year to Date Ended September 30, |  | Changes, quarter versus quarter Increase / (Decrease)
|  | 2020 |  | 2019 |
Cash provided by operating activities |  | $ | 29,457 |  |  | $ | 12,413 |  |  | $ | 17,044 |
Cash used in investing activities |  | (15,513) |  |  | (11,564) |  |  | (3,949) |
Cash provided by (used in) financing activities |  | 2,713 |  |  | (1,477) |  |  | 4,190 |
Increase (decrease) in cash and cash equivalents |  | $ | 16,657 |  |  | $ | (628) |  |  | $ | 17,285 |

Cash increased $16,657 for year to date ended September 30, 2020, compared to a decrease of $628 for year to date ended September 30, 2019, for a net increase in cash of $17,285, period versus period.
Operating Activities. Cash provided by operating activities for year to date ended September 30, 2020 was $29,457. The cash provided by operating activities during year to date ended September 30, 2020 resulted primarily from net income of $28,713, adjustments for non-cash or non-operating charges of $13,108 including depreciation and amortization, and share-based compensation, partially offset by uses of cash due to changes in operating assets and liabilities of $12,364. The primary drivers of the changes in operating assets and liabilities were $11,683 use of cash related to an increase in accounts receivables, net due to the timing of customer payments as well as increased sales during the quarter, $5,673 use of cash related to an increase in inventories, primarily barreled distillate, and $2,032 use of cash related to an increase in prepaid expenses due to an increase in prepaid insurance and vendor deposits. These uses of cash were partially offset by $5,647 cash provided by accrued expenses primarily related to incentive compensation expenses and $2,196 cash provided by accounts payable related to the timing of cash disbursements.
Cash provided by operating activities for year to date ended September 30, 2019 was $12,413. The cash provided by operating activities during year to date ended September 30, 2019 resulted primarily from net income of $25,846, adjustments for non-cash or non-operating charges of $12,103, including depreciation and amortization and share-based compensation, partially offset by uses of cash due to changes in operating assets and liabilities of $25,536. The primary drivers of the changes in operating assets and liabilities were $17,424 use of cash related to an increase in inventories, primarily barreled distillate, $3,236 use of cash related to accrued expenses, $2,138 use of cash related to refundable income taxes, primarily due to discrete items and lower than expected income before taxes, and $1,757 use of cash related to an increase in receivables, due to increased sales and timing of customer payments.
Investing Activities. Cash used in investing activities for year to date ended September 30, 2020 was $15,513, which resulted from additions to property, plant and equipment of $13,507 (see Capital Spending) and the acquisition of a business of $2,750, partially offset by proceeds from sale of property of $688. Cash used in investing activities for year to date ended September 30, 2019 was $11,564, which primarily resulted from additions to property, plant and equipment of $10,375 (see Capital Spending) and an increase in the deferred compensation plan investments of $1,189.
26

Capital Spending. We manage capital spending to support our business growth plans. Investments in property, plant and equipment were $13,507 and $10,375 for year to date ended September 30, 2020 and 2019, respectively. Adjusted for the change in capital expenditures in accounts payable for year to date ended September 30, 2020 and 2019, of $(2,654) and $(832), respectively, total capital expenditures were $10,853 and $9,543, respectively. We expect approximately $19,600 in capital expenditures in 2020 for facility improvement and expansion (including warehouse expansion), facility sustenance projects, and environmental health and safety projects.
As part of our strategic plan to support the growth of the American Whiskey category, we previously announced a warehouse expansion project. As of September 30, 2020, we had incurred approximately $49,900 of the total investment, which completes our current warehouse expansion project.
Financing Activities. Cash provided by financing activities for year to date ended September 30, 2020 was $2,713, primarily due to net proceeds from debt of $13,252 (see Long-Term and Short-Term Debt), partially offset by dividends and dividend equivalents of $6,144 (see Dividends and Dividend Equivalents) and purchases of treasury stock of $4,395 (see Treasury Purchases and Stock Repurchases).
Cash used in financing activities for year to date ended September 30, 2019 was $1,477, primarily due to net proceeds from debt of $9,212 (See Long-Term and Short-Term Debt), offset by purchases of treasury stock for tax withholding on share-based compensation of $5,470 (see Treasury Purchases) and payments of dividends and dividend equivalents of $5,141 (see Dividends and Dividend Equivalents).
Treasury Purchases. 30,404 RSUs vested and converted to common shares for employees during year to date ended September 30, 2020, of which we withheld and purchased for treasury 10,051 shares valued at $342 to cover payment of associated withholding taxes.
245,538 RSUs vested and converted to common shares for employees during year to date ended September 30, 2019, of which we withheld and purchased for treasury 77,014 shares valued at $5,468 to cover payment of associated withholding taxes.
Share Repurchases. On February 25, 2019, our Board of Directors approved a $25,000 share repurchase authorization commencing February 27, 2019, through February 27, 2022. Under the share repurchase program, we can repurchase stock from time to time for cash in open market purchases, block transactions, and privately negotiated transactions in accordance with applicable federal securities laws. This share repurchase program may be modified, suspended, or terminated by us at any time without prior notice. During the year to date ended September 30, 2020, 159,104 shares were repurchased under the program for $4,053.
Dividends and Dividend Equivalents

Dividend and Dividend Equivalent Information (per Share and Unit)
Declaration date |  | Record date |  | Payment date |  | Declared |  | Paid |  | Dividend payment |  | Dividend equivalent payment(a)(b) |  | Total payment(b)
2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |
February 24, 2020 |  | March 13, 2020 |  | March 27, 2020 |  | $ | 0.12 |  |  | $ | 0.12 |  |  | $ | 2,047 |  |  | $ | 13 |  |  | $ | 2,060 |
April 28, 2020 |  | May 22, 2020 |  | June 5, 2020 |  | 0.12 |  |  | 0.12 |  |  | 2,027 |  |  | 14 |  |  | 2,041 |
July 28, 2020 |  | August 21, 2020 |  | September 4, 2020 |  | 0.12 |  |  | 0.12 |  |  | 2,029 |  |  | 14 |  |  | 2,043 |
|  |  |  |  |  | $ | 0.36 |  |  | $ | 0.36 |  |  | $ | 6,103 |  |  | $ | 41 |  |  | $ | 6,144 |
2019 |  |  |  |  |  |  |  |  |  |  |  |  |  |
February 25, 2019 |  | March 13, 2019 |  | March 29, 2019 |  | $ | 0.10 |  |  | $ | 0.10 |  |  | $ | 1,701 |  |  | $ | 13 |  |  | $ | 1,714 |
April 29, 2019 |  | May 15, 2019 |  | May 31, 2019 |  | 0.10 |  |  | 0.10 |  |  | 1,702 |  |  | 11 |  |  | 1,713 |
July 29, 2019 |  | August 14, 2019 |  | August 30, 2019 |  | 0.10 |  |  | 0.10 |  |  | 1,703 |  |  | 11 |  |  | 1,714 |
|  |  |  |  |  | $ | 0.30 |  |  | $ | 0.30 |  |  | $ | 5,106 |  |  | $ | 35 |  |  | $ | 5,141 |

(a) Dividend equivalent payments on unvested participating securities.
(b) Includes estimated forfeitures.
27

On October 27, 2020, our Board of Directors declared a quarterly dividend payable to stockholders of record as of November 20, 2020, of the Company’s Common Stock, and a dividend equivalent payable to holders of certain RSUs as of November 20, 2020, of $0.12 per share and per unit, payable on December 4, 2020.
Long-Term and Short-Term Debt. We maintain debt levels we consider appropriate after evaluating a number of factors, including cash flow expectations, cash requirements for ongoing operations, investment and financing plans (including brand development and share repurchase activities) and the overall cost of capital. Total debt was $54,508 (net of unamortized loan fees of $1,401) at September 30, 2020, and $41,060 (net of unamortized loan fees of $448) at December 31, 2019.
Financial Condition and Liquidity. Our principal uses of cash in the ordinary course of business are for input costs used in our production processes, salaries, capital expenditures, and investments supporting our strategic plan, such as the aging of barreled distillate. Generally, during periods when commodities prices are rising, our operations require increased use of cash to support inventory levels.
Our principal sources of cash are product sales and borrowing on our Credit Agreement and Note Purchase Agreement. Under our Credit Agreement and Note Purchase Agreement, we must meet certain financial covenants and restrictions, and at September 30, 2020, we met those covenants and restrictions.
At September 30, 2020, our current assets exceeded our current liabilities by $176,679, largely due to our inventories, at cost, of $142,798. At September 30, 2020, our cash balance was $19,966 and we have used our Credit Agreement and Note Purchase Agreement for liquidity purposes, with $285,000 remaining for additional borrowings. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We regularly assess our cash needs and the available sources to fund these needs. While we currently believe we are well positioned with our credit agreement, we will continue to monitor the impact of the COVID-19 pandemic on our operations and liquidity needs. We utilize short-term and long-term debt to fund discretionary items, such as capital investments and dividend payments. In addition, we have strong operating results such that financial institutions should provide sufficient credit funding to meet short-term financing requirements, if needed.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to commodity price and interest rate market risks. We monitor and manage these exposures as part of our overall risk management program. Our risk management program focuses on the unpredictability of financial markets and seeks to reduce the potentially adverse effects that the volatility of these markets may have on our operating results.
Commodity Costs. Certain commodities we use in our production process, or input costs, expose us to market price risk due to volatility in the prices for those commodities. Through our grain supply contracts for our Atchison and Lawrenceburg facilities, our wheat flour supply contract for our Atchison facility, and our natural gas contracts for both facilities, we purchase grain, wheat flour, and natural gas, respectively, for delivery from one to 24 months into the future at negotiated prices. We have determined that the firm commitments to purchase grain, wheat flour, and natural gas under the terms of our supply contracts meet the normal purchases and sales exception as defined under Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, because the quantities involved are for amounts to be consumed within the normal expected production process.
Interest Rate Exposures. Our Credit Agreement and Note Purchase Agreement (Note 4) expose us to market risks arising from adverse changes in interest rates. Established procedures and internal processes govern the management of this market risk.
Increases in market interest rates would cause interest expense to increase and earnings before income taxes to decrease. The change in interest expense and earnings before income taxes would be dependent upon the weighted average outstanding borrowings during the reporting period following an increase in market interest rates. Based on weighted average outstanding variable-rate borrowings at September 30, 2020, a 100 basis point increase over the non-default rates actually in effect at such date would increase our interest expense on an annualized basis by $213. Based on weighted average outstanding fixed-rate borrowings at September 30, 2020, a 100 basis point increase in market rates would result in a decrease in the fair value of our outstanding fixed-rate debt of $1,704, and a 100 basis point decrease in market rates would result in an increase in the fair value of our outstanding fixed-rate debt of $1,802.
28

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures. As of the quarter ended September 30, 2020, our Chief Executive Officer and Chief Financial Officer have each reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have each concluded that our current disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Controls. There were no changes in the Company’s internal controls over financial reporting during the fiscal quarter ended September 30, 2020, that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Reference is made to Part I, Item 3, Legal Proceedings of our Annual Report on Form 10-K for the year ended December 31, 2019, and Note 7 to this Report on Form 10-Q for information on certain proceedings to which we are subject.
We are a party to various other legal proceedings in the ordinary course of business, none of which is expected to have a material adverse effect on us. On May 29, 2019 the Company was indicted in the U.S. District Court for the District of Kansas for alleged violations of the Clean Air Act related to a chemical release at the Company’s Atchison, Kansas facility on October 21, 2016. The Company and the Department of Justice resolved the allegations through a Plea Agreement entered with the Court on November 18, 2019, pursuant to which the Company agreed, among other things, to plead guilty to a misdemeanor negligent violation of the Clean Air Act and pay a fine of $1,000. On May 27, 2020, the Court accepted the Plea Agreement and sentenced the Company to pay a fine of $1,000 consistent with the terms of the parties’ resolution. The fine has been paid and the matter is terminated.
ITEM 1A. RISK FACTORS
Risk factors are described in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2019. The following update, listed below, should be read in conjunction with the risk factors disclosed in our Form 10-K for the year ended December 31, 2019.
A failure of one or more of our key information technology ("IT") systems, networks, processes, associated sites, or those of our service providers could have a negative impact on our business.
We rely on IT systems, networks, and services, including internet sites, data hosting and processing facilities and tools, hardware (including laptops and mobile devices), software and technical applications and platforms, some of which are managed and hosted by third party vendors to assist us in the management of our business. The various uses of these IT systems, networks, and services include, but are not limited to: hosting our internal network and communication systems; enterprise resource planning; processing transactions; summarizing and reporting results of operations; business plans, and financial information; complying with regulatory, legal, or tax requirements; providing data security; and handling other processes necessary to manage our business. Any failure of our IT systems or those of our third party vendors could adversely impact our ability to operate. Routine maintenance or development of new IT systems may result in systems failures, which may have a material adverse effect on our business, financial condition, or results of operations.
Increased IT security threats and more sophisticated cyber crime pose a potential risk to the security of our IT systems, networks, and services, as well as the confidentiality, availability, and integrity of our data. This could lead to outside parties having access to our privileged data or strategic information or information regarding our employees, suppliers or customers. Any breach of our data security systems or failure of our IT systems may have a material adverse impact on our business operations and financial results. If the IT systems, networks or service providers we rely upon fail to function properly, or if we or our third party vendors suffer a loss or disclosure of business or other sensitive information due to any number of causes, including power outages, computer and telecommunications failures, viruses, phishing attempts, cyber-attacks, malware and ransomware attacks, security breaches, natural disasters, and errors by employees, and the disaster recovery plans do not
29

effectively address these failures on a timely basis, we may suffer interruptions in our ability to manage operations and reputational, competitive, or business harm, which may have a material adverse effect on our business, financial condition, or results of operations. If our critical IT systems or back-up systems or those of our third party vendors were damaged or ceased to function properly, we might have to make a significant investment to repair or replace them. If a ransomware attack or other cybersecurity breach occurs, either internally or at our third-party technology service providers, it is possible we could be prevented from accessing our data which may cause interruptions or delays in our business, cause us to incur remediation costs or require us to pay ransom to a hacker which takes over our systems, or damage our reputation. In addition, such events could result in unauthorized disclosure of material confidential information, and we may suffer financial and reputational damage because of lost or misappropriated confidential information belonging to us or to our partners, our employees, customers, and suppliers. Additionally, we could be exposed to potential liability, litigation, governmental inquiries, investigations or regulatory enforcement actions and we could be subject to the payment of fines or other penalties, legal claims by our suppliers, customers or employees and significant remediation costs. Although we maintain insurance coverage for various cybersecurity risks, we may incur costs or financial losses that are either not insured against or not fully covered through our insurance.
Despite the protections we had in place, in May 2020, we were affected by a ransomware attack that temporarily disrupted production at our Atchison facilities. Our financial information was not affected and there is no evidence that any sensitive or confidential company, supplier, customer or employee data was improperly accessed or extracted from our network. We estimate that the ransomware attack adversely impacted gross profit by $1,728, primarily as a result of the business interruption. We have insurance related to this event and are seeking to recover a portion, if not all, of any profit impact including the profit associated with any loss of revenue resulting from this event.
Following the attack, we implemented a variety of measures to further enhance our cybersecurity protections and minimize the impact of any future attack. Cyber threats are constantly evolving however, and although we continually assess and improve our protections, there can be no guarantee that a future cyber event will not occur.
The outbreak of the coronavirus ("COVID-19") has negatively impacted and could continue to negatively impact the global economy. In addition, the COVID-19 pandemic could continue to disrupt or otherwise negatively impact global credit markets and could disrupt or otherwise negatively impact our operations, including the demand for our products and our ability to produce and deliver our products.
The significant outbreak of COVID-19 has resulted in a widespread health crisis, which has negatively impacted and could continue to negatively impact the global economy. In addition, the global and regional impact of the outbreak, including official or unofficial quarantines and governmental restrictions on activities taken in response to the outbreak, could have a negative impact on our operations, including voluntary or mandatory temporary closures of our facilities or offices; interruptions in our supply chain, which could impact the cost or availability of raw materials; disruptions or restrictions on our ability to travel or to market and distribute our products; reduced consumer demand for our products or those of our customers due to bar and restaurant closures or reduced consumer traffic in bars, restaurants and other locations where our products or those of our customers are sold; and labor shortages. More broadly, the outbreak could lead to an economic downturn that could affect future demand for our products and those of our customers.
Furthermore, our facilities and those of our customers and suppliers have been required to comply with additional regulations and may be required to comply with new regulations imposed by state and local governments in response to the COVID-19 pandemic, including COVID-19 safety guidance for production and manufacturing facilities. Compliance with these measures, or new measures, may cause increases in the cost, or delays or reduction in the volume, of products produced at our facilities or those of our suppliers.
The COVID-19 outbreak has disrupted credit markets, and may continue to disrupt or negatively impact credit markets, which could adversely affect the availability and cost of capital. Such impacts could limit our ability to fund our operations and satisfy our obligations.
The response to COVID-19 has resulted in in social distancing, travel bans, temporary closures of businesses, shelter-in-place orders, and quarantines, among other measures. Although certain of the restrictions have begun, and may continue, to ease in some places, the ongoing COVID-19 pandemic has limited and may continue to limit access to our facilities, customers, management, support staff, professional advisors and our independent auditors. These factors, in turn, may not only impact our operations, financial condition and demand for our products but our overall ability to react timely to mitigate the impact of this ongoing event. Also, these measures may continue to hamper our efforts to comply with our filing obligations with the Securities and Exchange Commission.
The extent and potential short and long-term impact of the ongoing COVID-19 outbreak on our operational and financial performance will continue to depend on future developments, including the duration, severity and spread of the virus, actions that may be taken by governmental authorities and the impact on our supply chain, customers, operations, workforce and the financial markets, all of which remain highly uncertain and cannot be predicted. These and other potential impacts of an
30

epidemic, pandemic or other health crisis, such as COVID-19, could therefore materially and adversely affect our business, financial condition and results of operations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
There was no unregistered sale of equity securities during the quarter ended September 30, 2020.
ISSUER PURCHASES OF EQUITY SECURITIES

|  | (1) Total Number of Shares (or Units) Purchased |  | (2) Average Price Paid per Share (or Unit) |  | (3) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |  | (4) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs |
July 1, 2020 through July 31, 2020 |  | 7 |  | (a) | $ | 30.70 |  |  | $ | — |  |  | $ | 20,947,113 |  | (b)
August 1, 2020 through August 31, 2020 |  | — |  |  | $ | — |  |  | $ | — |  |  | $ | 20,947,113 |  | (b)
September 1, 2020 through September 30, 2020 |  | — |  |  | $ | — |  |  | $ | — |  |  | $ | 20,947,113 |  | (b)
Total |  | 7 |  |  |  |  | $ | — |  |  |  |

(a) Vested RSUs awarded under the 2014 Plan purchased to cover employee withholding taxes.
(b) On February 25, 2019, our Board of Directors approved a $25,000 share repurchase authorization commencing February 27, 2019 through February 27, 2022. Under the share repurchase program, we can repurchase stock from time to time for cash in open market purchases, block transactions, and privately negotiated transactions in accordance with applicable federal securities laws. This share repurchase program may be modified, suspended, or terminated by us at any time without prior notice.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
31

ITEM 6. EXHIBITS

Exhibit Number | Description of Exhibit
10.1 | Second Amendment to Note Purchase and Private Shelf Agreement between MGP Ingredients, Inc. and certain noteholders affiliated with PGIM, Inc., dated September 30, 2020 (Incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed October 2, 2020 (File Number 000-17196))
*31.1 | CEO Certification pursuant to Rule 13a-14(a)
*31.2 | CFO Certification pursuant to Rule 13a-14(a)
*32.1 | CEO Certification furnished pursuant to Rule 13a-14(b) and 18 U.S.C. 1350
*32.2 | CFO Certification furnished pursuant to Rule 13a-14(b) and 18 U.S.C. 1350
*101 | The following financial information from MGP Ingredients, Inc.’s Quarterly Report on Form 10-Q for the quarter and year to date ended September 30, 2020, formatted in iXBRL (Inline Extensible Business Reporting Language) includes: (i) Condensed Consolidated Balance Sheets as of September 30, 2020, and December 31, 2019, (ii) Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2020 and 2019, (iii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2020 and 2019, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 and 2019, (v) Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2020 and 2019, and (vi) the Notes to Condensed Consolidated Financial Statements.
*104 | Cover Page Interactive Data Filed - formatted in iXBRL (Inline Extensible Business Reporting Language ) and contained in Exhibit 101
*Filed herewith |

32

SIGNATURES
Pursuant to the requirements on the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MGP INGREDIENTS, INC.

Date: | October 29, 2020 | By | /s/ David J. Colo
|  |  | David J. Colo, President and Chief Executive Officer
Date: | October 29, 2020 | By | /s/ Brandon M. Gall
|  |  | Brandon M. Gall, Vice President, Finance and Chief Financial Officer

33